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To study the impact of lactoferrin and lipids on the kinetic deposition and denaturation of 
lysozyme on conventional and silicone hydrogel contact lens materials.   
Methods 
The contact lens materials investigated in this thesis included two silicone hydrogel lenses [AIR 
OPTIX AQUA; lotrafilcon B and ACUVUE OASYS; senofilcon A] and two conventional 
hydrogel lenses [ACUVUE 2; etafilcon A and PROCLEAR; omafilcon A].  All four lens 
materials were incubated at 37
o
C in four different solutions:  a complex artificial tear solution 
(ATS) that consisted of various proteins, lipids, mucins and electrolytes; an ATS without 
lactoferrin; an ATS without lipids; and an ATS without lactoferrin and lipids.  Following each 
time point (4 and 12 hours, 1, 2, 3, 5, 7, 14, 21 and 28 days), the lens materials were removed 
from the incubation solutions for lysozyme analysis using the methods below:    
 To quantify the kinetic uptake of lysozyme to different contact lens materials, I125-
radiolabelled lysozyme was added to each incubation solution.  The total amount of 
lysozyme deposited on each lens type was quantified using a gamma counter. 
(Chapter 3)   
 To study the activity of lysozyme deposited to contact lenses, a novel fluorescence-based 
lysozyme activity assay was compared to the classical micrococcus turbidity assay.  
Potential interactions with different lens materials and protein extraction solvents were 
evaluated and the detection range for active lysozyme was determined.  (Chapter 4) 
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 To investigate the kinetic denaturation of lysozyme deposited to different contact lens 
materials, the fluorescence-based activity assay and the enzyme-linked immunosorbent 
assay were used. (Chapter 5)  
Results 
The presence of both lactoferrin and lipids significantly decreased lysozyme uptake to lotrafilcon 
B.  Lysozyme deposition on senofilcon A was greater in the absence of lipids after day 21, 
however the opposite was seen with etafilcon A, where lysozyme uptake was lower without 
lipids in the ATS.  Lactoferrin and/or lipids had no effect on lysozyme adsorption to omafilcon 
A.   
The novel fluorescence-based lysozyme activity assay demonstrated a high sensitivity and a wide 
linear range of detection, which covers the amount of lysozyme typically extracted from contact 
lenses.  Using this novel technique, kinetic lysozyme activity on both silicone hydrogel materials 
was shown to decrease in the presence of lipids in the ATS.  In addition, lactoferrin had a 
protective effect on lysozyme activity for lysozyme sorbed to senofilcon A.  Moreover, the 
presence of lactoferrin and/or lipids did not exhibit any effect on lysozyme denaturation with 
conventional hydrogel lens materials. 
Conclusions  
The presence of lactoferrin and lipids in an artificial tear solution impacted lysozyme deposition 
and denaturation of lysozyme on various contact lens materials.  The use of a complex artificial 
tear solution to investigate the adsorption of lysozyme and its reduction in activity on contact 
lenses exhibited results that were comparable to previous ex vivo studies, particularly results seen 
with silicone hydrogel lens materials.  It is important for future in vitro studies, when developing 
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tear film models, to consider the effects of various tear film components when investigating 
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1.1   Contact lenses 
  
Contact lenses are one of the most widely used biomedical devices in the world.
1
  The 
idea of using contact lenses to correct vision was first introduced in 1508 and has evolved 
tremendously over the ensuing 500 years.
2
  There are two main types of contact lens materials 
currently prescribed: soft hydrogel materials, which account for approximately 90% of contact 
lens fits, and rigid gas-permeable (RGP) materials which account for the remaining 10% of fits 
worldwide.
3
 The major factors that account for the greater preference for soft lenses over RGP 




1.1.1 Conventional hydrogel lenses 
 
Poly-2-hydroxyethyl methacrylate (pHEMA) has been the pre-eminent material utilized 
in the production of soft hydrogel contact lenses since the 1970s.  The incorporation of pHEMA 
in contact lenses allows superior water absorbance, 
5
 which increases lens wettability and initial 
comfort over rigid lenses.  Soft lens materials with a higher water content provide greater oxygen 
permeability (Dk), as the water phase dissolves oxygen and permits diffusion to the cornea.
6
 
Achieving higher Dk levels for contact lens materials is essential to reduce hypoxic 
complications such as corneal edema and acidosis.
7-9
 The maximum Dk of conventional 
hydrogels (which depend upon the water phase for oxygen transport) is dictated by the Dk of 
water, which has 80 Dk units. Therefore, although most hydrogel lenses contain high water 
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content, they do not provide the appropriate level of oxygen transmissibility (Dk/t) required for 
overnight or extended lens wear, in which oxygen levels are further reduced by eye closure.
10
   
1.1.2 Silicone hydrogel lenses 
 
In order to reduce the incidence of contact lens induced hypoxia, particularly during 
closed eye wear, scientists incorporated siloxane monomers into conventional hydrogel-based 
materials, to result in a new class of materials termed “silicone hydrogels”. In these materials, the 
siloxane components primarily improve oxygen permeability and the hydrogel components offer 
the water absorbing abilities that permit these materials to be soft and flexible.
11, 12
  Following 
their introduction in 1999, silicone hydrogel contact lenses became increasingly popular and are 
now the most commonly prescribed class of contact lens materials worldwide.
13
  These lenses 
greatly reduce hypoxia-related ocular complications for both daily and extended lens wear,
14-16
 
as their oxygen transmissibility is multiple times greater than most conventional hydrogel 
lenses.
17, 18
 The silicone component, however, creates a more hydrophobic lens surface, which 
consequently decreases lens wettability.
19
  Thus, many silicone hydrogel lens materials undergo 
surface modifications or incorporation of internal wetting agents to overcome this issue.  
Examples of surface modifications include a plasma coating over the surface of lens materials 
such as lotrafilcon A and B, as well as various other plasma treatments.
11, 19-21
  In a different 
approach, poly(vinyl pyrrolidone) has been integrated into silicone hydrogel lens materials, 
including senofilcon A and galyfilcon A, to increase the hydrophilicity of the contact lens. 
22
   
 The differing compositions and properties of conventional and silicone hydrogel lens 
materials ultimately make each lens type unique.  The United States Food and Drug 
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Administration (FDA) classifies and groups these lens materials based on their ionic charge and 
water content as follows:   
Table 1-1.  FDA classification of conventional and silicone hydrogel contact lenses 
FDA Classification Group I Group II Group III Group IV 
Water Content 
Low 
< 50% water 
High 
> 50% water 
Low 
< 50% water 
High 
> 50% water 
Charge 
Non ionic 
< 0.2% MA 
Non Ionic 
< 0.2% MA 
Ionic 
> 0.2% MA 
Ionic 
> 0.2% MA 
     FDA (Food and Drug Administration); MA (Methacrylic acid)  
  
 
 Water content and ionic charge of a lens material impacts the interaction between the lens 
and the tear film, leading to very specific deposition profiles during lens wear.  The following 
sections will discuss the three distinctive layers of the tear film and the major components in 




1.2   Tear film    
 
 The anterior surface of the eye is covered by a thin fluid film (approximately 3-7μm 
thick) known as the tear film.
23-25
 The tear film covers the underlying cornea and conjunctiva and 
serves to protect against foreign substances from the external environment, as well as 
maintaining the health of the eye.
26
 Most textbook models broadly divide the tear film into three 
layers: the lipid layer, which is the most superficial layer, the middle aqueous layer and the 
inner-most mucin layer.  Each layer contains various macromolecules that have specific tasks 
and assist in maintaining ocular health and function of the eye.
26
 While some recent publications 
propose that these layers are not distinct and consist of various graded layers, the description 
below (for simplicity) will report on the composition of the tear film based on this trilaminar 
structure.   
1.2.1 Lipid Layer 
 
 The meibomian glands are the primary source for the secretion of the lipid layer of the 
tear film.
27
  These sebaceous glands are lined in parallel to each other in the upper and lower 
tarsal plates, perpendicular to the lid margins.
28
  The lipid layer can be further divided into two 
phases, a polar and non-polar phase.
29-31
  The polar phase, which is closest to the external 
environment, is mostly composed of phospholipids such as phosphatidylcholine and 
phosphatidylethanolamine,
32
 and makes up less than 10% of the lipid layer.  In comparison, the 
non-polar phase, which is situated closest to the aqueous layer and forms the majority of the lipid 
layer, is composed primarily of cholesterol and cholesterol esters, as well as hydrocarbons and 
triglycerides.
29, 30, 32, 33
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 The lipid layer, which is approximately 0.1µm thick, serves as a protective barrier for 
both the eye and the tear film from foreign contaminants. 
34
  In addition, it provides stability for 
the tear film as it prevents the evaporation of tears when eyelids are opened, as well as 
maintaining a smooth tear film for the refraction of incoming light.
33, 35, 36
  Lastly, the lipid layer 
acts as a lubricant which assists in eyelid movement during the process of blinking.
35
          
 Given that the lipid layer plays a big role in tear film stability, any disturbance to the lipid 
layer composition would have significant clinical complications.  Meibomian gland dysfunction 
(MGD) is a chronic disease that is characterized by blockage of, or changes in, meibomian 
secretions.
37
 As a consequence, the amount of lipids in the tear film is decreased, which 
promotes rapid evaporation of tears, causing dry eye.
37
 Hence, the lipid layer is considered an 
important component in the tear film in maintaining the tear film intact over the anterior surface 
of the eye.       
1.2.2 Aqueous Layer 
 
 The aqueous layer is mainly produced by the lacrimal gland, and also by the accessory 
glands of Krause and Wolfring. 
38
  The aqueous layer makes up the bulk of the tear film, with a 
thickness of about 6-7 µm and is composed of water and various water-soluble proteins, 
vitamins, cytokines, immunoglobulins, hormones, electrolytes and metabolites.
38, 39
   The various 
electrolytes present in the aqueous layer include sodium, potassium, calcium, bicarbonates, 
chloride, and phosphate ions.  These electrolytes regulate tear osmolality, as well as acting as a 
buffer to maintain the physiological pH of tears.
38
  In previous studies, over 400 proteins have 
been identified in the human tear fluid.
40-42
  These different proteins and antimicrobial agents in 





  Amongst the large class of proteins, lysozyme, lactoferrin, lipocalin and secretory 
immunoglobulin A are found to be the most abundant in tears,
43
 and are all commonly involved 
in antibacterial activities.  The following paragraphs provide a brief description of the major 
proteins and their function in the aqueous layer.     
Lysozyme was discovered by Alexander Fleming in 1922 when he noticed that his nasal 
mucous, containing lysozyme, had wiped out an area of cultured bacterial cells.
44
 This 
observation was later discovered to be caused by lysozyme, which catalyzes the hydrolysis of 
1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in the 
peptidoglycan of Gram positive bacteria.
45
  As a result, the cell wall ruptures, which leads to 
bacterial cell lysis.  Lysozyme is primarily found in biological fluids such as mucous, saliva and 
tears and in only small concentrations in blood serum.  The concentration of lysozyme in tears 
ranges from 1.2 - 4.6mg/mL in the open eye, which is higher than all other bodily fluids.
46
  
Lysozyme has a relatively low molecular weight (14 kDa) and is positively charged at pH 7.4.
47, 
48
  It is relatively stable at temperatures up to 55° C and in solutions with pH as low as 1.0.
48, 49
 
Lactoferrin was first discovered as an iron chelator in human milk, but later in the 1960s, 
it was recognized to have bacteriostatic effects. 
50, 51
 Like lysozyme, lactoferrin is also found in 
many biological secretions such as saliva, milk and nasal secretions.  In tears, the concentration 
of lactoferrin ranges from 1.7 - 2.5mg/mL.
26, 52, 53
  Lactoferrin acts as an iron sequestering agent 
that allows it to chelate iron from bacteria, preventing bacterial growth.
54
  Studies have also 
suggested that lactoferrin can enhance the activity of other proteins such as lysozyme and 
secretory IgA to support the ocular defence mechanism. 
55-57
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Lipocalin has a molecular weight of 18-25 kDa and ranges from 1.2 – 1.7mg/mL in 
tears.
58, 59
  Lipocalin has multiple binding sites that allow it to bind to a large diversity of 
macromolecules, including lipids and proteins.
60-62
  Previous studies have suggested that 
lipocalin plays a large role in maintaining tear film stability by removing lipid contaminants from 
the ocular surface that prevent the proper formation of the tear film.
61, 62
  This is beneficial for 
proteins such as lysozyme, which are inactivated by long chain fatty acids.
63
  Furthermore, it has 
been suggested that negatively charged lipocalin in the tear film may bind to the positively 
charged proteins, lysozyme and lactoferrin, to perform synergistic antibacterial activities.
60
   
Immunoglobulins are a large group of proteins found in lacrimal glands, with secretory 
immunoglobulin A (sIgA) being the most predominant.
52
  The concentration of sIgA in tears 
ranges from 0.07 – 2.4mg/mL, which is much higher than in blood serum.
26
  The molecular 
weight of sIgA is 450kDa and is formed by two IgA molecules in conjunction with a secretory 
component.
64
  Secretory IgA has various roles in protecting the ocular surface from bacteria; it 
prevents microorganisms from binding to the ocular surface and promotes phagocytosis of 
bacteria by polymorphonculear leukocytes.
65, 66
   
1.2.3 Mucin Layer  
 
 Conjunctival goblet cells are the primary source of mucin secretion, which form the 
mucin layer that maintains a wettable corneal surface. 
67, 68
 The mucin layer is 0.2 – 1.0µm thick 
and contains immunoglobulins, enzymes, urea, salts and glucose.
69
 Mucins are large 
glycoproteins with molecular weights ranging from 3 × 10
5
 to over 4 × 10
7
 kDa and are classified 
as transmembrane or secretory mucins. 
70
 Transmembrane mucins form a protective barrier 
against pathogens at the epithelial cell-tear film interface, whereas secretory mucins move within 
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the tear film. 
71
 One of the primary functions of the mucin layer is to lubricate the palpebral 
conjunctiva, allowing smooth movements of the eyelid during blinking. 
67
   
 The moment a contact lens is fitted on the ocular surface, the tear film immediately 
interacts with the contact lens material, leading to various lens depositions.  The next section will 








1.3   Contact lens deposition  
 
1.3.1 Major deposited proteins  
Amongst all tear film components, proteins are the primary component that deposits on 
conventional hydrogel contact lenses during lens wear.  Lysozyme, lactoferrin and albumin are 
examples of major proteins that can typically be detected on worn contact lenses.
38, 72-75
   
 Lysozyme is a small compact protein that exhibits a strong positive charge in the tear 
film environment (pH 7.4) and selectively accumulates on various contact lens materials, 
particularly FDA group IV lenses materials.
48, 73, 76, 77
  Studies have reported that FDA group IV 
lens materials deposit approximately 1000µg of lysozyme, whereas the remaining FDA group I, 
II and III lens materials accumulate typically less than 60µg.
76, 78, 79
  Like lysozyme, lactoferrin is 
also positively charged, however less than 20µg of lactoferrin adsorb onto any of the four FDA 
materials
74, 80
  due to its greater molecular weight, fewer positive binding sites and overall lower 
charge.
81-83
  In contrast, the protein albumin has an overall negative charge and is found in lower 
concentrations in tears (10 - 24µg/mL).
84
  Albumin adsorbs in greater amounts on FDA group I 
lens materials compared to lysozyme and lactoferrin.
75
     
 Protein adsorption onto biomaterials such as contact lenses is a complex process and 
influenced by various factors.  Protein charge, size and concentration play key roles in the 





  Lens materials with an ionic charge will allow strong electrostatic interactions with 
oppositely charged proteins, thus further enhancing the level of uptake.
86, 87
  Protein deposition 
will also increase if the lens material has big enough pore sizes that allow the protein to 
diffusively penetrate into the matrix of the lens.
87
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 The process that leads to the deposition of proteins onto contact lenses can be divided 
into 3 steps:
88
   
1. Transport of protein towards the liquid-solid interface 
2. Attachment of protein at the interface 
3. Conformational changes of the adsorbed protein  
The initial transport step is simply the diffusion of the protein across the tears towards the lens 
surface.  Hence, higher concentrated proteins in the tears have a higher chance of interacting 
with the surface compared to proteins that are less abundant.
85
  When the protein binds to the 
surface of the lens it may undergo structural rearrangements in order to achieve the most 
thermodynamically favourable state.
88
  Proteins that have a strong structural stability undergo 
minimal structural changes, whereas proteins with lower internal coherence will adsorb to the 
surface even if structural rearrangements are unfavourable.
81
  Consequently, the adsorbed protein 
partially loses its tertiary and secondary structure and becomes “denatured”, which may result in 
a loss of its biological function.
89, 90
 There are several variables that influence the degree of 
denaturation of adsorbed proteins, including the amount of time the protein is bound to the 
surface, the hydrophobicity of the surface and the location of the deposited lysozyme on or in the 
lens material. 
79
 Lysozyme denaturation increases over time, and the rate is higher for lens 
materials that are relatively hydrophobic.
79
  It has further been suggested that lysozyme which 
penetrates into the lens matrix is less likely to denature than when tightly bound to the lens 
surface.
48, 79, 91





1.3.2 Major deposited lipids 
 Silicone hydrogel lenses deposit higher amounts of lipids as compared to conventional 
hydrogel lenses.
73, 92-94
 The deposition of lipids is primarily due to the adherence between the 
hydrophobic lipids with the hydrophobic sites on the lens material.
95
 Hence, because silicone-
based lens materials are relatively hydrophobic, tear film lipids are more likely to adhere during 
lens wear.  Over 45 different types of lipids have been identified in the tear film,
29-31
 but 
cholesterol, cholesteryl esters, triglycerides and waxy esters have been found to be major 
components in lipid deposits on contact lenses.
96-98
 Cholesterol and phosphatidycholine has also 
been recently shown to accumulate in higher amounts on silicone hydrogel lenses compared to 
FDA group IV lenses. 
92
   
 Like proteins that undergo structural changes following adsorption, lipids can undergo 
oxidative degradation, which occurs when lipids lose electrons under oxidative stress. 
99
  To date, 
there are a limited number of studies that have investigated the effects of contact lens wear on 
lipid oxidation. However, a previous study has associated increased amounts of lipid 
peroxidation products in tears with patients who suffer from dry eyes. 
100




1.4   Complications from contact lens deposition 
 







  These deposits may potentially decrease visual 
acuity and may cause dryness and discomfort, which ultimately leads to intolerance and 
discontinuation of lens wear.
106-110
  Certain tear film deposits have further shown to promote 
bacterial adhesion,
111-113
 which may increase the risk of ocular infections such as bacterial 
keratitis.        
Another clinical concern associated with contact lens deposits is the initiation of 
inflammatory responses.  Denatured protein on contact lenses has been associated with a 
condition known as contact lens induced papillary conjunctivitis (CLPC).
114, 115
 Symptoms of 
CLPC typically include ocular redness, increased mucus production due to ocular irritation, 
burning, itching, increased lens awareness and lens intolerance.
116
  CLPC can develop during 
rigid and soft hydrogel lens wear, however it is more commonly seen in soft hydrogel lens 
wearers and symptoms are also typically noted sooner with hydrogel lens wear.
116-118
  Although 
the exact cause of CLPC is unclear, many factors may promote its development.  It was 
previously suggested that tear film deposits on the lens surface act as an antigenic stimulus, 
which leads to the production of various immunoglobulins and immune response initiators such 
as C3 anaphylatoxin (C3a).  These immunoglobulins, along with C3a, interact with mast cells 
and basophils, leading to a release of vasoactive amines, which are responsible for the 
development of CLPC symptoms.  In addition, the presence of a contact lens can also cause 
mechanical trauma to the conjunctiva, which leads to a production of inflammatory mediators 
and a subsequent recruitment of leukocytes to the conjunctiva.  These leukocytes will interact 





Hence, the development of CLPC can be initiated by the presence of deposits on contact lenses, 





 and ex vivo
104, 120
 studies have investigated the deposition of proteins 
and lipids on conventional and silicone hydrogel contact lenses over the past few decades.  These 
studies have used numerous methods to identify and quantify protein and lipids deposits, which 
will be discussed in the subsequent sections.  For the purpose of this thesis, the sections will 





1.5   Quantification of protein deposits on contact lenses 
 
 The quantification and identification of deposited proteins typically require the extraction 
of the tear film deposit from the lens material prior to analysis.  In the past, different solvents 
have been used to remove the protein from the contact lens, including sodium dodecyl sulfate 
(SDS), ethylenediaminetetraacetic acid (EDTA), urea and TrisHCl.
102, 121-123
  The use of heat and 
sonication in combination with extraction solvents increases the efficiency of protein removal 
from biomaterials.
124, 125
  Unfortunately, most extraction procedures are ineffective in removing 
100% of the protein deposited on a lens.
126
  More recently, Keith et al.
72
 introduced a more 
efficient extraction solvent, consisting of trifluoroacetic acid and acetonitrile, which can remove 
up to ~100% of the total lysozyme from certain lens materials.  Many studies have since utilized 
this technique.
79, 104, 120, 123, 127
  Following the elution procedure, the extracted proteins can be 
quantified using a variety of methods, that will be described below.   
1.5.1 Bicinchoninic acid (BCA) analysis 
 The principle behind the BCA analysis is based on two separate reactions:  Proteins in an 
alkaline solution containing copper ions (Cu
+2
) reduce the Cu
+2 




    
The bicinchoninic acid in the solution then reacts with the Cu
+1 
ions, resulting in the formation of 
a purple colored complex.
128
  The color intensity of this reaction product increases in proportion 
to increasing protein concentrations in the sample and can be measured spectrophotometrically.  
This method is highly sensitive and shows low protein-to-protein variation compared to other 
protein assays.
128
  However, in samples containing multiple proteins, the BCA assay will be 




1.5.2 High performance liquid chromatography (HPLC) 
 HPLC is a chromatographic method used to separate proteins based on molecular size,
129
 
for the purposes of identifying and quantifying proteins in a complex solution, like the tear film.  
The separation procedure involves mass transfer between stationary and mobile phases.  The 
proteins in the sample are added to a solvent, which is then forced to flow through a 
chromatographic column to separate the individual proteins in the mixture.  As each protein 
component exits from the HPLC, a detector identifies and quantifies the individual proteins in 
the solution based on their retention time. 
129
  Unlike the BCA assay, the HPLC method is able to 
quantify individual proteins in a complex protein mixture.  However, a previous study
130
 had 
found that lysozyme exhibits unusual high absorbance in the HPLC, which consequently 
interferes with the HPLC measurements.        
1.5.3 Western blotting and enzyme-linked immunosorbent assay (ELISA)  
 Western blotting is another technique used to quantify proteins extracted from contact 
lenses.  This technique identifies and quantifies proteins in a sample using antibodies specific to 
the protein of interest.
131
 The proteins in the sample are first separated by gel electrophoresis and 
subsequently transferred to a nitrocellulose or polyvinylidene fluoride (PVDF) membrane.
131
 The 
membrane is then stained by antibodies to visualize the proteins.   
 The enzyme-linked immunosorbent assay (ELISA) is a similar technique that uses 
antibodies for protein detection.  ELISA relies on the recognition of the protein under test by a 
detection antibody that is covalently bonded to an enzyme.
132
 Once the antibody is bound to the 
protein of interest, a substrate (dye) that produces a visible color in the presence of the enzyme is 
added.
132
 The intensity of the signal produced by the enzyme-substrate reaction is proportional to 
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the amount of a specific protein in the sample.  The ELISA technique can process up to 96 
samples at once, which is a major advantage over the Western blotting technique.        
1.5.4 Radiolabelling of proteins  
 Radiolabelling is a highly sensitive in vitro technique, which provides a quick and simple 
way to quantify the protein of interest deposited onto contact lenses.  This technique allows a 
simultaneous detection of proteins on the lens surface and in the bulk and does not necessitate 
the protein be extracted from the lens.  Furthermore, this technique has been shown to be 
compatible with all contact lens materials.
75, 76, 78, 80, 133-136
  A disadvantage of this technique is 
the possibility of the radioactive isotope detaching from the protein of interest and interacting 
with other components in a complex solution or with the contact lens material and therefore 
generating false results.  Hence a dialyzing procedure is often utilized in order to reduce the 
amount of free radioactive isotopes in the solution.   
1.5.5 Methods to determine protein denaturation 
 The conformational state of deposited proteins on contact lenses is of clinical relevance 
due to its association with ocular inflammatory conditions.  Different techniques have been used 
to study the structural arrangement of deposited proteins, such as electron spin resonance (ESR) 
spectroscopy and Fourier transform infrared-attenuated total reflectance spectroscopy (FTIR-
ATR).
137, 138
  The microccocal turbidity assay is specifically used for lysozyme and relies on the 
lytic activity of this enzyme against Micrococcus lysodeikticus bacteria.
73, 77, 79, 120, 123
  These 
Gram positive bacteria form a yellow colored solution, when suspended in a buffer.  When active 
lysozyme is then added, the decrease in optical density (OD) of the solution can be monitored 
over time.  The greater the concentration of active lysozyme, the quicker the solution becomes 
17 
 
transparent.  This method has been used previously to monitor the kinetic denaturation of 
lysozyme extracted from silicone and conventional hydrogel lens materials.
79
   
 Enzchek® is a novel fluorescence-based lysozyme activity assay that effectively detects 
active lysozyme in cell culture.
139, 140
 Like the turbidity assay, the fluorescence-based assay relies 
on the lytic activity of lysozyme on the fluorescently tagged Micrococcus lysodeikticus.  As the 
bacteria are lysed, the reaction products release a fluorescence signal that is used to quantify the 
amount of active lysozyme in the sample.  Although this novel method has been shown to have 
high sensitivity and a wide range of detection,
141
 to date it has not been used in contact lens 







1.6   In vitro, in vivo and ex vivo studies 
 
 In vitro, (Latin: “in glass”), refers to experimental investigations that are conducted 
outside of a living organism.  The purpose is to study biological properties in a controlled 
environment, rather than in a human or animal.  In contrast, in vivo, (Latin: “in life”), refers to 
studies that are done in/on a living organism.  Sometimes, the living tissue can be extracted from 
a human or animal and studied in another artificial environment outside of the organism.  This 
type of experimentation is referred to as ex vivo, (Latin: “out of the living).  In vitro and ex vivo 
studies are often preferred over in vivo studies as they allow the experimental testing on certain 
aspects of a living organism that would typically be impossible to conduct on an intact organism.  
However, the main disadvantage for conducting in vitro studies is that they often struggle to 
closely mimic in vivo conditions in order to produce results that correlate with real life outcomes.  
The following table summarizes the advantage and disadvantages of conducting in vitro and in 




Table 1-2.  Advantages and disadvantages of in vitro and in vivo studies 






 Study biological properties 
that would normally be 
inconvenient if conducted 
in vivo 
 
 Relatively inexpensive and 
quicker than in vivo studies 
 
 Experimental variables are 
controlled by researcher 
 
 Key components can be 
isolated from the system 
and studied individually 
 
 
 Results directly translate to 
real life outcomes 
 
 Includes all parameters that 
normally influence the 






 Difficult to mirror  
in vivo conditions 
 
 Results may not always 
correlate with in vivo results 
 
 
 Cost and time demanding 
 
 Difficult to make cause and 




Over the past years, a large number of in vitro studies
76, 78, 81, 82, 136
 have been conducted 
to investigate protein deposition on contact lens materials, however, most of these studies 
incubate their contact lenses in solution containing only one protein of interest.
75, 77, 80, 81, 135
  
These incubation solutions do not take into account the impact of other tear film components and 
as a result protein sorption profiles differ between in vitro and ex vivo studies.
73, 77, 104, 142





2. Thesis Rationale 
 
Tear film deposition on contact lens materials have been investigated extensively.  
Protein deposits are often associated with reductions in visual acuity and may lead to symptoms 
of dryness and discomfort during lens wear.  In more severe cases, denaturation of proteins on 
the lens material may trigger immunological responses, leading to ocular complications such as 
papillary conjunctivitis.  Thus, protein adsorption and changes in protein conformation during 
the deposition process have attracted much attention from both clinicians and scientists.   
Lysozyme is a major protein constituent of the human tear film and has been shown to 
selectively deposit to various lens materials, particularly negatively charged hydrogel materials.  
For these reasons, lysozyme is often used as a model protein for contact lens deposition studies.  
A number of previous in vitro studies have investigated lysozyme accumulation and denaturation 
on both silicone and conventional hydrogel lenses.  However, these studies often incubated their 
lenses in a simplistic solution composed of lysozyme dissolved in phosphate buffered saline.  
These incubation solutions are not accurate portrayals of the human tear film, which contains 
numerous proteins, lipids, mucins and electrolytes.  To enable the interactions between tear film 
components and to allow competitive uptake during the deposition process, a more complex 
artificial tear solution was used to study the impact of major tear film components on lysozyme 
deposition and denaturation on contact lens materials. 
In the first study of this thesis (Chapter 3), an artificial tear solution was used to 
investigate the impact of major tear film components on the deposition profile of lysozyme to 
silicone and conventional hydrogel lenses.  The tear film protein lactoferrin and tear lipids were 
selected, as they represent primary components of the tear film. Lactoferrin is a positively 
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charged protein which has a similar abundance in the tear film as lysozyme and plays a major 
role in defence against ocular surface infection.  Tear lipids are primarily found in the outermost 
layer of the tear film and prevent excessive evaporation of the tears, thus maintaining the 
stability of the tear film.  Some of these lipids have primarily hydrophobic properties and deposit 
in relatively high amounts on silicone hydrogel lenses.   
 In Chapter 4 of this thesis, a novel fluorescence-based assay was compared with the 
classical micrococcus turbidity assay to determine the activity of lysozyme.  The traditional 
micrococcus turbidity assay is time consuming and has difficulties detecting low levels of active 
lysozyme.  Recently, a novel fluorescence-based lysozyme activity assay was developed for cell 
culture studies, which is more time efficient and can detect lower amounts of active lysozyme 
when compared to the turbidity assay.  This novel method had not previously been used in 
contact lens studies and a validation study was undertaken to investigate its utility for 
investigating lysozyme activity with soft lens polymers.  
 The last study of this thesis (Chapter 5) investigated the effects of lactoferrin and lipids 
on lysozyme activity when deposited on silicone and conventional hydrogel lenses.  Lactoferrin 
is known for its bacteriostatic function, and in combination with lysozyme it has a synergistic 
effect on the lytic activity of lysozyme against Gram positive bacteria.  However, it was unclear 
whether lactoferrin may also have an effect on the activity of lysozyme during the adsorption 
process.  Various contact lens materials were used to confirm the hypothesis that lysozyme 
denatures more quickly on relatively hydrophobic surfaces.  In addition, the presence of lipid 
may change the hydrophilicity of the contact lens surface, which could impact the denaturation 
rate of a subsequent lysozyme layer. 
22 
 
 The results from this thesis will determine the impact of major tear film components on 
the deposition profile of lysozyme to different contact lens materials. It will also confirm 
whether the use of an artificial tear film model that closely resembles the human tear film is able 
to more accurately mimic the amount and conformational state of deposited lysozyme that occurs 






3. Impact of Tear Film Components on Lysozyme Deposition  
to Contact Lenses 
 
 
This chapter is reproduced with permission from:  
Ng A, Heynen M,Luensmann D, Jones L. Impact of tear film components on lysozyme 
deposition to contact lenses. Optom Vis Sci 2012; 89:392-400.  











3.1   Overview 
 
Purpose: To investigate the impact of lactoferrin and lipids on the kinetic deposition of lysozyme 
on silicone and conventional hydrogel lenses, using a complex artificial tear solution. 
Methods: Two silicone hydrogel lenses [AIR OPTIX AQUA; lotrafilcon B and ACUVUE 
OASYS; senofilcon A] and two conventional hydrogel lenses [ACUVUE 2; etafilcon A and 
PROCLEAR; omafilcon A] were investigated. Lenses were incubated in four different solutions: 
A complex artificial tear solution (ATS) consisting of various salts, lipids, proteins and mucins, 
an ATS without lactoferrin (ATS w/o Lac), an ATS without lipids (ATS w/o Lip) and an ATS 
without lactoferrin and lipids (ATS w/o Lac & Lip), each containing 2% radiolabeled (125I) 
lysozyme (1.9mg/ml). After each time point (4, 12hours and 1, 2, 3, 5, 7, 14, 21, 28 days), the 
amount of lysozyme per lens was quantified. 
Results: After 28 days, lotrafilcon B lenses incubated in ATS deposited significantly less 
lysozyme (9.7±1.4µg) than when incubated in solutions not containing lactoferrin and lipids 
(>11.8 µg) (p<0.001). Lysozyme uptake to senofilcon A lenses was higher in ATS w/o Lip 
(5.3±0.1µg) compared to other solutions (<3.9µg) (p<0.001). Etafilcon A lenses deposited the 
most lysozyme in all solutions compared to the rest of the lens types (p<0.001). For etafilcon A 
lenses, less lysozyme was deposited when incubated in ATS w/o Lip (588.6±0.4µg) compared to 
the other solutions (>642.6µg) (p<0.001). Omafilcon A lenses in ATS w/o Lac accumulated 
significantly less lysozyme (12.8±1.0µg) compared to the other solutions (>14.2µg) (p<0.001). 
Conclusions: An ATS containing lactoferrin and lipids impacts lysozyme deposition on both 
silicone and conventional hydrogel contact lenses. When using in vitro models to study protein 
25 
 






3.2   Introduction 
 
Contact lenses are biomedical devices used to correct vision and it is estimated that over 
125 million people in the world are contact lens wearers
1
 Despite their popularity, dryness and 
lens discomfort, particularly at the end of the day, continue to be common concerns and have 
become the primary reasons for discontinuation of contact lens wear.
2-4
 The cause for dryness 
and discomfort has been linked to tear film deposition onto contact lenses in some studies.
5-7
   
A number of in vitro
8-10
 and ex vivo
11, 12
 studies have investigated tear film protein 
deposition on silicone and conventional hydrogel lens materials.  Simple in vitro models are 
often used to predict ex vivo results due to lower costs and time commitments compared to more 
complex in vivo studies. In vitro studies that have investigated protein deposition on contact 
lenses have typically relied on the use of very simplistic tear film models,
9, 13
 which may not be a 
very accurate portrayal of the human tear film. Very few studies have evaluated the differences 
between ex vivo and in vitro models and it is relatively unclear which components of the human 
tear film primarily influence the accumulation of certain tear proteins to contact lenses.
14, 15
    
The tear film is a complex aqueous solution consisting of various lipids, proteins, 
metabolites and electrolytes.
16, 17
  Within this complex composition, lysozyme is found to be the 
most abundant protein.
18, 19
  Lysozyme is a small bacteriolytic enzyme (14 kDa)
20, 21
 that 
interferes with the specific bonds responsible for protecting and maintaining the shape of the 
exoskeleton in the bacterial cell wall.
22
  Lysozyme has a large net positive charge thus allowing 
it to bind relatively easily to negatively charged substrates.
23-25
  Lysozyme has drawn much 
attention in contact lens deposition studies in recent years due to its selective absorbance to ionic 
contact lens materials.
23







 and inflammatory conditions involving papillary changes in the tarsal conjunctiva 
known as giant papillary conjunctivitis.
11, 27, 28
     
Tear film deposition on contact lens materials has been previously shown to be mediated 
by the physical properties of the lens surface such as surface charge and hydrophobicity.
23, 29, 30
  
Lysozyme binds in high amounts to ionic polyhydroxyethylmethacrylate (pHEMA) hydrogels, 
while only a fraction of this level of deposition is typically seen on silicone hydrogel  
lenses.
5, 9, 10, 31-33
  However silicone hydrogel materials appear to deposit lipids relatively 
quickly
34
 and at higher amounts compared to pHEMA lenses.
32
  In addition, another major 
protein found in the tear film, lactoferrin, has shown similar characteristics to lysozyme in 
selectively binding onto ionic pHEMA-based contact lenses.
25, 35
   
As described above, it is accepted that the composition of contact lens materials 
determines subsequent tear film deposition. However, little is known about the importance of the 
tear components on protein uptake and whether it has the same impact for different materials.  
Therefore, the purpose of this study was to investigate the impact of individual tear film 
components on the kinetics of lysozyme deposition to silicone and conventional hydrogel lens 
materials using a complex artificial tear solution (ATS). 
3.3   Materials and Methods 
 
In this in vitro study, two silicone hydrogel and two conventional pHEMA-based lens 
materials were investigated. All lenses were unworn, with a power of -3.00 Diopters (D) and 
their individual properties are summarized in Table 3-1.   
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Table 3-1.  Properties of contact lens materials investigated in this study 
 Silicone Hydrogel Conventional Hydrogel 




ACUVUE OASYS ACUVUE 2 PROCLEAR 
Manufacturer CIBA Vision Johnson & Johnson  Johnson & Johnson  CooperVision 








FDA group I I IV II 











DMA - N,N-dimethylacrylamide; FDA - Food and Drug Administration; HEMA - (poly-2-hydroxyethyl 
methacrylate);  MA - methacrylic acid; mPDMS - monofunctional polydimethylsiloxane; PC - phosphorylcholine; 
PVP - polyvinyl pyrrolidone; TEGDMA - tetraethyleneglycol dimethacrylate; TRIS - trimethylsiloxy silane; USAN 






3.3.1 Artificial Tear Solution (ATS) 
 
Contact lenses were incubated in an ATS consisting of a mixture of proteins, lipids, 
mucins, salts, glucose (all Sigma-Aldrich Canada Ltd., Oakville, ON, Canada) and urea (EMD 
Science, VWR, Mississauga, Canada) and were adjusted to a physiological pH of 7.34.  The 
detailed composition of the ATS is based on a previous study by Lorentz et al
36
 (see Table 3-2).  
In order to examine the impact of lactoferrin and lipids on lysozyme deposition, the contact 
lenses were incubated in four different solutions (Table 3-3).   
Table 3-2.  Artificial tear solution components 
Salt Components (mg/mL) Lipid Components (mg/mL) 
NaCl 5.26 Oleic Acid 0.018 
KCl 1.19 Oleic Acid Methyl Ester 0.012 
Na2CO3 1.27 Triolein 0.016 
KHCO3 0.30 Cholesterol 0.0018 
CaCl2 0.07 Cholesteryl Oleate 0.024 
Na3C6H5O7 0.44 Phosphotidylcholine 0.0005 
Urea 0.072  
Glucose 0.036 Protein Components (mg/mL) 
Na2HPO4 3.41 Bovine Albumin 0.20 
HCl 0.94 Hen Egg Lysozyme 1.90 
  Bovine Mucin 0.15 
ProClin 300 200µL per litre of solution Bovine IgG 0.02 









Table 3-3.  List of solution combinations used for incubation 
Solution  
1 Complex ATS with all its tear film components (ATS) 
2 ATS without lactoferrin (ATS w/o Lac) 
3 ATS without lipids (ATS w/o Lip) 
4 ATS without lactoferrin and lipids (ATS w/o Lac & Lip) 
ATS (artificial tear solution); Lac (lactoferrin); Lip (lipids) 
 
3.3.2 Pre-treatment of vials and lenses 
 
Previous work in our laboratory demonstrated that the glass vials (6mL, Wheaton Science 
Products, Millville, NJ, USA) used during the lens incubation period bound proteins and lipids to 
their walls.  Specifically, up to 80% of the lipids from the ATS bound to the glass walls of the 
vials within four days of incubation, resulting in a reduction in their concentration within the 
soaking solution. Therefore, to prevent loss of macromolecules to the glass surface during lens 
incubation, the vials were pre-treated for 7 days with 1.5mL of solution at 37
o
C. The solution 
used for the pre-treatment phase matched the subsequent solution used for lens incubation, with 
the exception of lactoferrin, which was excluded from the pre-treating solution due to cost 
considerations.  Each solution was replaced with fresh solution for incubating the lens materials. 
 Prior to the incubation, lenses were removed from their blister packages using sterile 
silicone tipped forceps, rinsed in a saline solution for 2 seconds and then immersed in 5mL of an 
augmented buffered saline solution containing the salt components listed in Table 3-2, at room 





. This pre-soaking step was performed to remove any blister pack 
solution and prevent potential carryover into the incubation solutions. 
3.3.3 Incubation of lenses  
 
 Following pre-treatment, the pre-treating solution was removed from the vials and 
subsequently replaced by 1.5mL of one of the four incubation solutions.  Lenses were placed in 
individual vials and incubated at 37
o
C.  In order to study the kinetics of the lysozyme deposition, 
lenses were incubated for ten different time periods (4 and 12 hours, 1, 2, 3, 5, 7, 14, 21, and 28 
days).  Three replicates for each condition were used, thus a total of 480 contact lenses was used 
in the study.  Each lens type was incubated in 1.5mL of incubation solution, with the exception 
of the etafilcon A lenses, which were soaked in 6.0mL.  The reason for this extra volume is that 
previous work (unpublished) demonstrated that the amount of lysozyme uptake to this lens 
material is more than that available in 1.5mL,
9, 10
 which resulted in total depletion of the 
lysozyme from this volume of solution before the lens material was “saturated”.  For this reason, 
a higher volume of incubation solution for etafilcon A lenses were used to ensure a sufficient 
amount of lysozyme for maximum uptake.   
3.3.4 Quantifying lysozyme deposits on lenses 
 
To quantify the amount of lysozyme deposited on lenses, each solution contained 98% 
hen egg lysozyme (HEL), with the remaining 2% lysozyme being conjugated with a radioactive 
iodine isotope (I
125
), which was used as a reporter molecule.  Following each time point, lenses 
were removed from the solution using sterile forceps and rinsed in a complex salt solution for 2 
seconds to remove unbound lysozyme from lenses.  Afterwards, lenses were blotted dry on lens 
paper and inserted into culture tubes (VWR, Mississauga, ON, Canada). Lysozyme uptake on 
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each lens was quantified by counting radioactive lysozyme using a gamma counter (1470 Wallac 
Wizard PerkinElmer, Woodbridge, ON, Canada).   
3.3.5 Statistical analysis 
 
Data analysis was conducted using Statistica 8 software (StatSoft Inc, Tulsa, OK, USA). 
A repeated measures analysis of variance (ANOVA) was used to determine statistically 
significant differences between lysozyme deposition across various time points and between 
materials. A post-hoc Tukey-HSD (Honestly Significant Difference) test was performed. A p 
value of <0.05 was considered significant.  Lysozyme deposition was considered to plateau when 
no significant increase was found between the respective time point and day 28 (p>0.05).   
3.4   Results 
 
A comparison of kinetic lysozyme uptake between the four materials revealed that 
etafilcon A lenses deposited significantly higher amounts of lysozyme with all four solutions at 
any time point, compared to the other lens materials (p<0.001). The amount of lysozyme 
deposited on the etafilcon A material after only 4 hours of incubation was significantly greater 
than the amount of lysozyme deposited on the other three materials after 28 days of incubation 
(p<0.001).  In contrast, senofilcon A lenses deposited lower amounts of lysozyme in comparison 
to the other 3 lens types throughout the 28 day period (p<0.001).    
 Figure 3-1 displays the kinetic lysozyme uptake to lotrafilcon B using the four different 
solutions.  Within the first 4 hours of incubation, lysozyme deposition when incubated in the 
ATS was significantly lower (6.1±0.4µg) compared to the ATS without lactoferrin (8.4±0.4µg), 
the ATS without lipids (12.3±0.5µg) and the ATS without lactoferrin and lipids (13.4±0.9µg) (all 
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p<0.001).  There was a significant difference in average lysozyme uptake to lotrafilcon B lenses 
between all four incubating solutions following the 28 days (p<0.001).  Furthermore, incubation 
in ATS without lactoferrin and lipid yielded significantly greater lysozyme uptake compared to 
the other solutions throughout the 28 days (p<0.001).  Incubation in ATS without lipids 
displayed significantly greater lysozyme deposition compared to the amounts deposited from an 
ATS without lactoferrin (p<0.001).  At the end of the 28 day incubation period, the total amount 
of lysozyme deposited on lotrafilcon B lenses when incubated in ATS was significantly less 
(9.7±1.5µg) than in ATS without lactoferrin and lipids (17.0±1.6µg) and ATS without lactoferrin 
(11.8±0.4µg) and ATS without lipids (15.8±0.8µg) (p<0.001).  The amount of lysozyme uptake 
reached a plateau at 12 hours when exposed to ATS without lactoferrin and lipids, whereas 
incubation in ATS without lactoferrin and ATS without lipids displayed a plateau in deposition 
at the beginning of day 1 (p>0.05).  Lastly, a plateau was reached on day 5 of incubation in the 




Figure 3-1.  Kinetic lysozyme uptake to lotrafilcon B lenses over a period of 28 days.  The 
solutions used for incubation were a complex artificial tear solution with multiple tear film 
components (ATS) , an ATS without lactoferrin (ATS w/o Lac) , an ATS without lipids 
(ATS w/o Lip)  and an ATS without lactoferrin and lipids (ATS w/o Lac & Lip) . 
 
Figure 3-2 shows the kinetic lysozyme deposition on senofilcon A lenses after incubation 
in all four solutions. Following the first 4 hours of incubation, the amount of lysozyme uptake 
between the four incubation solutions was no higher than 1.5±0.1µg.  There were no significant 
differences in lysozyme uptake between the four incubation solutions until after 12 hours of 
incubation, where lysozyme uptake was significantly greater in ATS without lipids compared to 
ATS (p<0.001).  Higher amounts of lysozyme were also detected using ATS without lipids 
between study day 2 and day 28 compared to ATS without lactoferrin (p<0.001).  In addition, 
lysozyme deposition with ATS without lipids was greater than with ATS without lactoferrin and 
lipids from day 21 onwards (p<0.001).  At the end of the day 28, total lysozyme accumulated 
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from incubating in ATS without lipids was significantly higher (5.3±0.1µg) compared to the 
other solutions, where deposition was no more than 3.9µg (p<0.001).  Lysozyme deposition 
reached a plateau on senofilcon A lenses at day 14 when incubated in ATS, ATS without 
lactoferrin and ATS without lactoferrin and lipids (p>0.05).  There was no plateau when lenses 
were incubated in ATS without lipids by the end of the 28 day incubation period (p<0.001).    
 
Figure 3-2.  Kinetic lysozyme uptake to senofilcon A lenses over a period of 28 days.  The 
solutions used for incubation were a complex artificial tear solution with multiple tear film 
components (ATS) , an ATS without lactoferrin (ATS w/o Lac) , an ATS without lipids 
(ATS w/o Lip)  and an ATS without lactoferrin and lipids (ATS w/o Lac & Lip) . 
 
The kinetic lysozyme deposition on etafilcon A lenses after incubation with all four 
solutions is displayed in Figure 3-3.  Within 4 hours of incubation, etafilcon A lenses 
accumulated greater than 225.8±0.2µg of lysozyme in each of the incubation solutions. After the 
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first 12 hours, kinetic lysozyme deposition on etafilcon A lenses was significantly less using the 
ATS without lipids compared to the ATS without lactoferrin and lipids (p<0.001).  Lysozyme 
uptake from incubating in ATS without lipids was significantly less after day 3 compared to ATS 
without lactoferrin (p<0.001).  Furthermore, after day 5, lysozyme deposition was found to be 
significantly less when incubated in ATS without lipids compared to ATS (p<0.001).  Total 
lysozyme accumulated from incubating in ATS without lipids was significantly lower 
(588.6±0.4µg) compared to the other solutions where the total amount of lysozyme uptake was 
more than 642.6µg at the end of day 28 (p<0.001).  A plateau in lysozyme deposition on 
etafilcon A lenses was reached in all incubating solutions by day 7 of incubation (p>0.05).       
 
Figure 3-3.  Kinetic lysozyme uptake to etafilcon A lenses over a period of 28 days.  The 
solutions used for incubation were a complex artificial tear solution with multiple tear film 
components (ATS) , an ATS without lactoferrin (ATS w/o Lac) , an ATS without lipids 
(ATS w/o Lip)  and an ATS without lactoferrin and lipids (ATS w/o Lac & Lip) . 
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Figure 3-4 shows the kinetic lysozyme uptake to omafilcon A using the four solutions.  
Overall, lower amounts of lysozyme were detected on omafilcon A lenses when incubated in 
ATS compared to the ATS without lipids or ATS without lactoferrin and lipids (p<0.001).    
Lysozyme deposition was also shown to be significantly lower in ATS without lactoferrin 
compared to ATS without lipids and ATS without lactoferrin and lipids (p<0.001).  After 4 
hours, omafilcon A lenses deposited more than 6.3±0.3µg of lysozyme in each of the incubation 
solutions.  Incubating in ATS displayed significantly lower lysozyme deposition from the 
beginning of day 1 to day 7, compared to ATS without lipids (p<0.001). However, the lysozyme 
deposited from these two solutions were comparable after day 7 (p>0.05).  Lysozyme uptake 
using the ATS without lactoferrin and ATS without lactoferrin and lipids were comparable in the 
first week of incubation (p>0.05). However, lysozyme deposition became significantly greater in 
ATS without lactoferrin and lipids following 14 days of incubation (p<0.001).  In addition, the 
exposure to ATS without lactoferrin displayed comparable amounts of lysozyme accumulation 
for the first 2 weeks compared to ATS and ATS without lipids (p>0.05) up to day 14, where 
lysozyme deposition became significantly less in ATS without lactoferrin (p<0.001).  At the end 
of day 28, total lysozyme deposition from incubating in ATS without lactoferrin was 
significantly less (12.8±1.0µg) compared to the other solutions, where uptake was more than 
14.2µg (p<0.001).  Lysozyme uptake began to plateau at day 14 in ATS without lactoferrin and 
in ATS without lactoferrin and lipids, whereas a plateau began at day 21 in ATS and in ATS 




Figure 3-4.  Kinetic lysozyme uptake to omafilcon A lenses over a period of 28 days.  The 
solutions used for incubation were a complex artificial tear solution with multiple tear film 
components (ATS) , an ATS without lactoferrin (ATS w/o Lac) , an ATS without lipids 
(ATS w/o Lip)  and an ATS without lactoferrin and lipids (ATS w/o Lac & Lip) . 
 
 The following data points had one measurement removed from the triplicate 
measurements:    Lysozyme sorption to senofilcon A in ATS w/o Lip and in ATS w/o Lac and 
Lip on Day 3 (Fig. 3-2), to etafilcon A in ATS w/o Lip on Day 1 and Day 21 (Fig. 3-3) and to 
omafilcon A in ATS w/o Lip on Day 14 (Fig. 3-4).  These values were greater than 2 standard 
deviations from the mean of the other two measurements and were considered an outlier.  In each 




3.5   Discussion 
 
This study outlines the effects of lactoferrin and lipids on lysozyme deposition to 
conventional and silicone hydrogel lens materials monitored over a period of 28 days using an in 
vitro model.     
3.5.1 Silicone hydrogel lenses  
 
Lipid deposition on silicone and conventional hydrogel materials have been previously 
investigated and results have shown lipid uptake to silicone hydrogels is greater than on 
conventional hydrogels.
32, 34, 37
  The two silicone hydrogel lenses in this study, lotrafilcon B and 
senofilcon A, possess a lower water content of 33% and 38% respectively, compared to the 
pHEMA-based materials, etafilcon A and omafilcon A with 58% and 62%, which may influence 
the adherence of ATS components to the lens material.  In addition, siloxane-based contact lens 
materials are more hydrophobic, allowing lipids to be more readily deposited because of the 
favorable hydrophobic to hydrophobic interaction at the lens surface.
38
 This could explain the 
greater amount of lysozyme deposition on lotrafilcon B and senofilcon A lenses when incubated 
in ATS without lipids (Figure 3-1 and 3-2):  Without the presence of lipids in the solution, there 
are more sites available for lysozyme to attach to the lens material.  On the contrary, when lipids 
are introduced, the accumulation of lipids on FDA group I lenses may perhaps outcompete 
lysozyme uptake because of the thermodynamically favorable binding of lipids.  Although it has 
been shown that proteins bind more readily to hydrophobic than hydrophilic surfaces,
39, 40
 our 
results suggest that the hydrophobic characteristic of group I lenses still have a greater attraction 
for lipids than for lysozyme and lactoferrin, since the presence of lipids markedly reduces the 
40 
 
binding of lysozyme. This has significant importance when developing an in vitro incubating 
solution to investigate protein deposition.        
Lotrafilcon B and senofilcon A lens materials attract only low amounts of protein 
compared to ionic conventional lens materials.
5, 9, 10, 32, 33, 41
  Lysozyme and lactoferrin both have 
a net positive charge, however their charges are unevenly distributed around their protein 
structure, thus allowing these tear film proteins to bind to various materials.
42
  Lysozyme 
deposition on lotrafilcon B lenses was greater with lactoferrin absent in the ATS than when 
incubated in the complex ATS, which possibly may be due to competition with lactoferrin for 
binding sites on the lens surface.  A previous study by Santos et al
43
 has examined the protein 
content deposited on lotrafilcon B lenses that were worn on a daily basis for one month and 
found higher amounts of lactoferrin deposited on these lenses than lysozyme.  This may suggest 
lotrafilcon B lenses have a stronger affinity to lactoferrin than lysozyme, which would explain 
the impact of the presence of lactoferrin on lysozyme uptake to lotrafilcon B lenses.  On the 
contrary, there were no differences in lysozyme uptake to senofilcon A lenses with or without 
lactoferrin present in the ATS.  This difference in deposition behavior between the two silicone 
hydrogel lenses could be due to the differences in the surface treatment processes of each lens 
type.  Lotrafilcon B lenses are treated in a gas plasma reactive chamber to create a permanent 
ultrathin (25nm) continuous hydrophilic surface. Senofilcon A lenses do not have any surface 
treatment but contain an internal wetting agent (polyvinyl pyrrolidone; PVP) to assist lens 
wettability.
44-46
  Santos et al 
43
 previously compared the wettability of a similar silicone hydrogel 
lens containing PVP (galyfilcon A) with lotrafilcon B lenses.  The authors reported that the 
surface treatment on lotrafilcon B lenses and the internal wetting agent (PVP) in galyfilcon A 
lenses exhibited comparable effects on lens wettability.  Thus, the application of a surface 
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treatment or the incorporation of an internal wetting agent in lenses does not seem to account for 
the differences in lysozyme uptake, but rather the differences in chemical composition of the lens 
materials that alters the deposition of lysozyme.       
3.5.2 Conventional hydrogel lenses  
 
Lysozyme bound to the etafilcon A material in the presence of tear film components at 
very high levels (greater than 200µg after 4 hours of incubation) compared to the rest of the 
lenses investigated (less than 20µg after 28 days of incubation).  These results agree with 
previous studies that have shown protein deposition on FDA group IV lenses are greater than on 
group I and II lenses.
29, 47-49
  This is largely due to the ionic interactions between tear film 
proteins such as lysozyme and the lens material.  FDA group IV lenses typically contain 
negatively charged methacrylic acid (MA) to increase the water content of the material, which 
results in a strong electrostatic attraction to net positively charged proteins such as  
lysozyme.
13, 47, 50
 At a normal physiological pH, the ionized groups in MA repel one another, 
causing an increase in distance between chains, allowing pores to be formed.
51
 These sequences 
of events allow proteins to adsorb and penetrate into the hydrogel matrix.  In contrast, previous 
reports have shown the presence of phosphorylcholine in contact lenses hinders protein 
deposition,
52-55
 which further supports the data from this study, where omafilcon A lenses 
deposited low amounts of lysozyme.   
 Lactoferrin and lysozyme are abundant antibacterial proteins from the tear film, both 
being positively charged.  Although similar, lactoferrin is greater in size (74 kDa) and possesses 
a relatively weaker positive charge compared to lysozyme.
25
 Sariri and colleagues
25
 have 
previously shown that ionic etafilcon A lenses deposit both lactoferrin and lysozyme, however 
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greater amounts of lysozyme were found compared to lactoferrin and the differences in size and 
relative charge strength account for these uptake differences.  In the current study, no differences 
were seen in lysozyme uptake to etafilcon A lenses incubated in an ATS compared to an ATS 
without lactoferrin and lipids (Figure 3-3).  However, removing lipids from the ATS decreased 
the amount of lysozyme deposition.  These results suggest that lipids may either promote the 
binding of lysozyme to the lens surface or prevent lactoferrin adsorption from the ATS, thus 
presenting more attachment sites for lysozyme to bind. The former is unlikely, as a previous 
study has shown that the addition of lipids to an incubating solution decreases the amount of 
lysozyme uptake on group IV lenses.
13
 Bontempo and Rapp’s proposed reason is that lysozyme 
attachment on group IV lenses promotes attachment of non polar lipids and as a result hinders 
further lysozyme binding.  Thus, it remains unclear whether lipids inhibit lactoferrin adsorption 
on group IV lenses.  Lactoferrin, a member of the transferrin family of proteins, has the ability to 
bind to various cells and anions, which implies it has various binding motifs and binding sites.
56
  
A study that investigated the interactions between tear proteins with the meibomian lipid film 
demonstrated that both lysozyme and lactoferrin are capable of binding to lipids.
57
  It is possible 
that lipids have a greater attraction to lactoferrin than lysozyme and as a consequence, the 
adsorption of lactoferrin on etafilcon A lenses is reduced in the presence of lipids, allowing 
lysozyme to better compete for binding sites on the lens.  However, future studies should focus 
on understanding the impact of lipids and other tear film components on the deposition of 
lactoferrin on both silicone and conventional hydrogel lens materials.       
 Previous studies showed that group II lens materials, such as omafilcon, are more prone 
to deposit lipids and less protein compared to group IV materials.
29, 58, 59
 Although there were 
overall no significant differences (p>0.05) in lysozyme deposition between the two ATSs 
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without lipids (ATS without Lip and ATS without Lac and Lip), both deposited more on the 
omafilcon material compared to the other two solutions containing lipids.  These findings further 
support the hypothesis that with the presence of lipids in an incubating solution, lysozyme 
deposition on omafilcon A lenses would be less, compared to an environment where lipids are 
absent. 
3.5.3 Comparison to in vitro and ex vivo studies   
 
From the current study, the presence of lactoferrin and lipids created variations in 
lysozyme deposition on both silicone and conventional hydrogel lens materials, which varied 
between lens materials.  The lysozyme uptake patterns are in reasonable agreement with a 
previous in vitro study by Subbaraman et al,
9
 and both studies showed that etafilcon A lenses 
demonstrate a large increase in lysozyme deposition during the first week of incubation and then 
shows a plateau for the remaining 3 weeks, while omafilcon A lenses illustrate a steady increase 
in lysozyme deposition throughout the 4 weeks.  However, lysozyme uptake was drastically 
lower for etafilcon A and omafilcon A lenses in this current study when incubated in the 
complex ATS (647.0±1.57µg and 14.9±0.6µg respectively) compared to the results from 
Subbaraman and co-workers
9
 (1434.5±56µg and 43.8±13µg respectively), which used a single 
protein solution for incubation. We believe this is due to the presence of lipids within the ATS 
competing for binding sites in the lens. Moreover, differences in the lysozyme deposition curve 
were noted for the senofilcon A material between the two studies. In this study, lysozyme only 
slowly increases over the course of the 28 days and shows a plateau effect after day 14. In the 
previous study,
9 
 lysozyme uptake continues to increase over time and does not plateau by the 
end of 28 days. Subaraman et al
9
 also showed differences in the amount of lysozyme quantified 
on lotrafilcon B and senofilcon A lenses (6.1±1.3µg and 13.4±4.1µg respectively) at the end of 
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28 days compared to when incubated in ATS in the current study (9.7±0.5µg and 3.45±0.3µg 
respectively).  Our data would also suggest that there are other factors apart from lactoferrin and 
lipid that influence deposition, as variations in lysozyme uptake between this current study and 
the Subbaraman in vitro study
9
 were evident when comparing the data from the ATS without 
lactoferrin and lipids.  Thus, this comparison between the use of a single protein solution and an 
incubating solution that contains multiple tear film components demonstrates the existence of 
competitive interactions of tear film components on and throughout contact lens materials.     
To evaluate the accuracy of the ATS used in this study as a model of the tear film, ex vivo 
studies were reviewed to compare lysozyme deposition on worn lenses to the lenses incubated in 
the ATS.  Boone et al
11
 quantified lysozyme deposition on bi-weekly worn lotrafilcon B and 
senofilcon A lenses using western blot.  The amount of lysozyme deposited on lotrafilcon B 
lenses (0.3±0.2µg) and senofilcon A lenses (1.6±1.6µg) were lower compared to the quantified 
amounts in the current study (10.4±0.3µg and 3.2±0.1µg respectively).  The differences may be 
reflected by the use of lens care solutions during these ex vivo studies, which remove a certain 
amount of lysozyme from the lenses.  On the contrary, ex vivo studies typically found higher 
amounts of lysozyme deposition (~1000µg) on worn etafilcon A lenses compared to the results 
from this study.
31, 33, 60
 The lower amount of lysozyme deposition obtained from in vitro 
incubated etafilcon A lenses compared to the worn lenses could perhaps be explained by the 
rapid decrease in lysozyme concentration in the ATS as lysozyme deposits on the lenses.  This is 
different in vivo when fresh tears are secreted and spread over the surface of the cornea with each 
blink, whereas the lenses in this study were kept in the same ATS throughout the entire 
incubation process until they were retrieved for lysozyme quantification.  Future in vitro studies 
should aim to replenish the ATS in the vials during the incubation period.  In addition, the 
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current in vitro model is limited in a way that it does not expose lenses in an air-water interface, 
which would have been a better representation for lens wear.  Future studies would require the 
development of an artificial eye model that incorporates tear replacement with blinking 
movements to better mimic in vivo conditions during contact lens wear.  Furthermore, because 
the efficiency of protein removal by lens care solutions are dependent on lens material and 
protein type, 
61, 62
 the incorporation of utilizing lens care solutions on incubated lenses could 
further investigate and explain the differences in protein removal on different lenses by various 
lens care products as shown in previous ex vivo studies.   
3.6   Conclusion 
 
 In summary, both lactoferrin and lipids exhibit an impact on the kinetic uptake of 
lysozyme to silicone and conventional hydrogel materials.  The amount of lysozyme deposited 
on each lens type, as well as the relative effect of lactoferrin and/or lipids on lysozyme 
deposition, was lens material dependent.  Overall, the presence of lipids exhibited a greater effect 
than lactoferrin in reducing lysozyme deposition on both FDA group I and II lenses.  In 
comparison, the presence of lactoferrin decreased the amount of lysozyme deposition on group 
IV lenses.  Interestingly, by adding lipids to the ATS, the effect of decreasing lysozyme uptake 
on etafilcon A lenses by lactoferrin was diminished.  The deposition patterns of lysozyme from 
the current study that utilized a newly developed artificial tear solution varied from previous in 
vitro studies that used simplified tear film models. Interactions between tear film components 
and their competitive binding on these lens materials might be responsible for this difference.  In 
conclusion, when using in vitro models to study protein deposition on contact lenses, more 
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4.1   Overview 
 
Purpose:  To optimize a novel fluorescence-based lysozyme activity assay to investigate the 
conformational state of lysozyme in solution and to determine the impact of extraction and 
evaporation procedures on lysozyme activity. 
Methods:  The fluorescence-based lysozyme activity assay, Enzchek (Molecular Probes Inc, 
Eugene, OR) which utilizes fluorescently quenched Micrococcus lysodeikticus, was compared to 
the classical lysozyme turbidity assay using four differently concentrated lysozyme samples (20, 
10, 5.0 and 2.0ng/µL).  Furthermore, six differently concentrated lysozyme samples (2.0, 1.0, 
0.5, 0.25, 0.125 and 0.01µg/µL) were quantified using the fluorescence-based assay in the 
presence of extraction solvents consisting of 0.2% and 0.02% trifluroacetic acid/ acetonitrile 
(TFA/ACN) and following evaporation procedures.   
Results:  A standard curve was generated by the fluorescence-based assay ranging from 2ng – 
150ng.  The total active lysozyme quantified in the four lysozyme samples were not significantly 
different between the two assays (p>0.05) and the concordance correlation coefficient was 
determined to be 0.995.  However an average discrepancy between the two assays was found to 
be 0.474ng, with the turbidity assay typically reporting higher active lysozyme measurements. 
The sensitivity of the fluorescence-based assay was higher than the classical turbidity assay 
when quantifying 20ng or less active lysozyme.  Following extraction and evaporation 
procedures and the addition of lens extracts,  the total active lysozyme recovered was 95% or 
greater.       
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Conclusions:  In comparison to the classical turbidity assay, the fluorescence-based assay is a 
very sensitive method, making it a favourable technique, particularly when studying contact lens 





4.2   Introduction 
 
Lysozyme, also known as muramidase or N-acetylmuramide glycanhydrolase, is a 
ubiquitous bacteriolytic enzyme found in most biological secretions, including saliva, mucous 
and tears.
1, 2







 and immunological studies.
8
  
Lysozyme was first discovered in 1922 by Alexander Fleming 
9
 and since then has been well 
known for its antibacterial property.  Fleming discovered that his nasal drippings, containing 
natural lysozyme, triggered the death of bacterial cells in his Petri dish.
9
 This phenomenon is 
now known to be caused by the lysozyme-catalyzed hydrolysis of 1,4-beta-linkages between N-
acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan of the bacterial cell 
wall.
10
  Consequently, the damaged bacterial cell wall loses its structural integrity and ruptures, 
which results in subsequent cell death.     
The concentration of lysozyme found in human tears is the highest of all body fluids (1.7 
to 1.9 mg/ml in the open eye),
11
 accounting for 40% of the total protein content of tears.
12, 13
 This 
enzyme provides antibacterial protection against microbes that may cause ocular infections such 
as bacterial keratitis.
14
  Lysozyme concentration decreases significantly in the tears of patients 
with Sjögren’s syndrome and in patients exhibiting ocular toxicity due to long term practolol 
therapy (a beta adrenergic blocking agent for treatment of cardiovascular disorders).
15
  Patients 
diagnosed with herpes simplex virus infection and children with malnutrition also demonstrate 
reduced lysozyme levels in their tears.
15
 Thus, the quantification of lysozyme in patients’ tears 
provides a valuable diagnostic aid to detect symptoms of various health complications.      
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Lysozyme has shown to selectively deposit onto both conventional and silicone hydrogel 
contact lens materials,
16-20
  with conventional hydrogel lenses accumulating higher levels of 
lysozyme than silicone hydrogel materials.
16, 20, 21
 However, although silicone hydrogel lenses 
deposit significantly lower quantities of protein, the degree and the rate of lysozyme denaturation 
is relatively higher on these materials.
22
  The conformational state of these deposited proteins is 
of significant interest because higher levels of denatured proteins have been associated with an 
ocular inflammatory response known as contact lens associated papillary conjunctivitis 
(CLPC).
23-26
 Higher amounts of denatured proteins have further been linked to reduced comfort 
during contact lens wear.
27
  
In the past, in vitro
17, 22
 and ex vivo
28
 studies have investigated the conformational state of 
lysozyme on contact lenses, by measuring the activity of extracted lysozyme from lens materials 
using a turbidimetric lysozyme activity assay.
17, 22, 28-30
 This turbidity assay utilizes Micrococcus 
lysodeikticus as a substrate and relies on the lytic activity of lysozyme.  This method determines 
the kinetic changes in the conformational state of lysozyme; however it is often time consuming 
when processing a large number of samples.  Furthermore, the turbidity assay is also relatively 
low in sensitivity and has a narrow linear range of detection,
31
 which presents some difficulties 
when quantifying active lysozyme from contact lens materials that deposit low amounts of 
lysozyme.
22
  Most recently, a novel fluorescence-based lysozyme activity assay kit became 
commercially available, which has been shown to have high sensitivity in cell culture studies.
32, 
33
  However, to our knowledge, this assay has not previously been investigated in studies looking 
at the activity of lysozyme extracted from contact lens materials. Thus, the aim of this study was 
to optimize this novel fluorescence-based assay to investigate the conformational state of 
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lysozyme in solution and to determine the impact of extraction and evaporation procedures on 
lysozyme activity.      
4.3   Materials and Methods 
 
To compare a novel fluorescence-based assay with the classical turbidity assay, four 
differently concentrated solutions of hen egg lysozyme (HEL, Sigma-Aldrich, St. Louis, MO, 
USA) (at 20, 10, 5.0, and 2.0ng/µL) were used in this study.  Three replicates were prepared to 
assess the validity and repeatability of the fluorescence-based assay.       
4.3.1 Classical turbidimetric assay  
 
 The turbidity assay was adapted from previous contact lens studies.
17, 22, 28
  Fresh 
Micrococcus lysodeikticus was re-suspended in sodium phosphate buffer (pH 6.3) and adjusted 
to an initial optical density (OD) of 1.1 at 450nm (Multiskan Spectrum ELISA Plate Reader, 
ThermoLab systems).  Samples and standards of no more than 10µL were added in cuvettes 
containing 1.0mL bacteria.  The assay was set to run for 5 minutes at 31
o
C and the change in OD 
at 450nm was recorded at 30 second intervals, with stirring for 10 seconds after each 
measurement.  The rate in OD change was calculated and subsequently compared to a standard 
curve to determine the mass of active lysozyme in each sample.  The standard curve was 
generated by adding different volumes (10, 8, 6, 4, and 2µL) of a 12µg/µL lysozyme standard 
into a cuvette.  The lower limit of detection for the turbidity assay was established by the lower 
quantity of lysozyme that produces a detectable change in OD. 
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4.3.2 Fluorescence-based lysozyme activity assay 
 
 The EnzChek® lysozyme activity assay (Molecular Probes Inc, Eugene, OR, USA) 
measures total active lysozyme using fluorescently-quenched Micrococcus lysodeikticus.  As the 
bacteria are lysed in the presence of lysozyme, an increase in fluorescent signal in proportion to 
the amount of active lysozyme in the sample is seen.
31
 In this study, the substrate was re-
suspended in a 1X reaction buffer (0.1M sodium phosphate, 0.1M NaCl, pH 7.5, containing 
2mM sodium azide as preservative).  Standards and samples (50µL) were added to 50µL of 
substrate using 96 well black microplates (Costar, Fisher Scientific, VWR, Mississauga, 
Canada). The assay was set to run for 30 minutes using excitation/emission of 485/530nm at 
37
o
C (SpectraMax M5 Multi-Mode Microplate Reader, Molecular Devices, Sunnyvale, CA, 
USA).  Given that up to 96 samples can be processed at once for each 30 minute assay, the time 
required to process each sample is significantly less compared to the turbidity assay. To follow 
the kinetics of the reaction, fluorescence was measured every 2 minutes, with 5 seconds of plate 
shaking before each reading. The change in fluorescence over time for each sample was 
compared to a standard curve to determine the total amount of active lysozyme.  The standard 
curve was generated by performing a 2X serial dilution using a 12µg/µL lysozyme standard.  
The limit of detection for the fluorescence-based assay was established by the lowest quantity of 
lysozyme that produces a detectable change in fluorescence. 
4.3.3 Using the fluorescence-based assay for contact lens extracts 
 
 The steps involved in the quantification of contact lens deposits include (1) the extraction 
of the proteins from contact lenses and (2) the drying of the extracted proteins by evaporation 
followed by (3) the quantification method.
17, 22, 28
  To investigate the effects of (1) and (2) on 
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lysozyme conformation, 50µL of six differently concentrated HEL samples (2.0, 1.0, 0.5, 0.25, 
0.125, and 0.01µg/µL) were added to 500µL of two differently concentrated protein extraction 
solvents: 0.2% and 0.02% trifluroacetic acid/ acetonitrile (TFA/ACN). The use of TFA/ACN is a 
common technique for protein extraction and has been previously used to remove deposited 
protein from patient-worn contact lenses.
12, 17, 22, 28, 34
 Following the incubation in extraction 
buffer, all samples were dried down using a Savant Speed Vac (Halbrook, NY, USA). The 
negative controls were the six HEL samples measured without the addition of extraction solvents 
and evaporation. All samples were diluted to fall within the detection range and then measured 
using the fluorescence-based assay.   
 The effect of the contact lens extracts on the novel fluorescent-based assay was also 
investigated. To determine the impact of lens extracts on the outcome of the fluorescence-based 
assay, two silicone hydrogel lenses: lotrafilcon B (Air Optix Aqua, CIBA Vision) and senofilcon 
A (Acuvue OASYS, Johnson & Johnson Vision Care) and two conventional hydrogel lenses: 
etafilcon A (Acuvue 2, Johnson & Johnson Vision Care) and omafilcon A (Proclear, 
CooperVision) were investigated.  Following a 24 hour pre-soaking step in saline solution to 
remove any blister pack solution, lenses were individually immersed for 24 hours in either 0.2% 
or 0.02% TFA/ACN solvents. The lens materials were not exposed to proteins prior to 
extraction.  In previous studies,
28, 34, 35
 the 0.2% TFA/ACN solvent was used to extract proteins 
from lotrafilcon B, etafilcon A and omafilcon A lenses, whereas 0.02% TFA/ACN was used for 
senofilcon A.  Six differently concentrated lysozyme samples (as described above) were then 
added to 500uL of the lens extracts for each lens type. The negative controls were lysozyme 
samples in the extraction solvents (without lens extracts). Subsequently, all samples were dried 
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down by evaporation, diluted to fall within the range of detection and immediately processed by 
the fluorescence-based assay.   
4.3.4 Lysozyme quantification 
 
 In addition to determining active lysozyme, the total amount of lysozyme present in all 
samples was quantified by an enzyme-linked immunosorbent assay (ELISA).
36
  Initially, three 
replicates of 50µL of each sample were added into flat bottom 96-well plates (Maxisorp 
certified, Thermo Scientific, VWR, Mississauga, Canada) and kept at room temperature for 2 
hours.  Subsequently, the wells were washed 3x using 300µL of the wash buffer (Phosphate 
buffered saline, PBS) and 200µL of 3% bovine serum albumin in PBS was added to block any 
additional binding sites. After 2 hours, the wells were washed again 3x, followed by adding 
50µL of 1/1300 rabbit anti-chicken lysozyme antibody (Meridian Life Science, MJS BioLynx, 
Memphis, TN, USA) to the sample. After 1.5 hours of incubation, wells were once again washed 
3x and 50µL of the 1/5000 donkey anti-rabbit IgG-horseradish peroxidase linked antibody (Santa 
Cruz Biotechnology Inc., Santa Cruz, CA, USA) was added. Following 1 hour of incubation, 
wells were washed again 3x and 50µL of 3,3'5,5',-tetramethylbenzidine reagent (Sigma-Aldrich 
Canada, Oakville, ON, Canada) was added. The plate was incubated for 5 minutes in the dark 
and finally 50µL of 1M H2SO4 was added to stop the reaction. The OD of each well was 
measured at 450nm using the SpectraMax M5 Multi-Mode Microplate Reader). The OD 
measurements were compared to a standard curve to determine the total amount of lysozyme in 




4.3.5 Percentage of active lysozyme 
 
 The percentage of active lysozyme quantified in each sample was calculated as follows: 
% Active Lysozyme  =  (Active Lysozyme / Total Amount of Lysozyme)   X   100% 
4.3.6 Statistical analysis  
 
Data analysis was conducted using Statistica 8 software (StatSoft Inc, Tulsa, OK, USA). 
The correlation of the active lysozyme measurements quantified by the two activity assays was 
assessed by calculating the concordance correlation coefficient.
37
  A comparison between the 
two assays was further done using a Bland-Altman plot.
38
 In addition, a repeated measures 
analysis of variance (RM-ANOVA) was used to determine statistically significant differences in 
lysozyme activity after extraction and evaporation and between the four lens extracts. A post-hoc 
Tukey-HSD (Honestly Significant Difference) test was performed and a p-value of <0.05 was 
considered significant. 
4.4   Results 
 
 The standard curve produced by the classical turbidity assay is seen in Figure 4-1.  The 
range of detection for the turbidity assay was found to be between 20-120ng.  The linear 
regression equation and the correlation coefficient for the standard curve were y = 0.0003x - 
0.0013 and R² = 0.995.  Figure 4-2 displays the standard curve of the fluorescence-based activity 
assay, which ranged from 2ng to 150ng.  The linear regression equation and the correlation 
coefficient of the standard curve were y = 0.0308x + 0.3653 and R² = 0.997.             
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y = 0.0003x - 0.0013
R² = 0.995
 
Figure 4-1.  The standard curve of lysozyme was determined with the turbidity assay, by 
measuring the change in optical density (OD) of the Micrococcus lysodeikticus solution over 
time (minutes). 




























y = 0.0308x + 0.3653
R² = 0.997
 
Figure 4-2.  The standard curve of lysozyme was determined with the fluorescence-based assay, 
by measuring the change in fluorescence (RFU) of the fluorescently-tagged Micrococcus 
lysodeikticus in the solution over time (minutes). 
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Measurements of active lysozyme generated by the turbidity assay and the fluorescence-
based assay are shown in Figure 4-3.  The concordance correlation coefficient between the 
results from the two assays was рc = 0.995 and the upper and lower 95% confidence interval 


































y = 0.992x + 0.8558
pc = 0.995
 
Figure 4-3.  Correlation between active lysozyme measurements of four differently concentrated 
lysozyme samples (20, 10, 5.0, 2.0ng/µL) quantified by the fluorescence-based assay and the 
turbidity assay. 
 
A comparison between the turbidity assay and the fluorescence-based assay was further 
made using a Bland-Altman plot (Figure 4-4).  The bias of the distribution was calculated to be 
0.474, indicating that the turbidity assay determined on average a slightly higher content of 
active lysozyme compared to the fluorescence-based assay.  All data points were found to lie 
within the 95% limits of agreement, which ranged from -4.72 to 5.67.           
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Average Active Lysozyme Measurements  by




















































































Figure 4-4.  Bland-Altman plot of the amounts of active lysozyme quantified by the turbidity 
assay and the fluorescence-based assay.  The Y-axis measures the difference in active lysozyme 
measurements between the two assays (turbidity – fluorescence-based assay) and the X-axis 
measures the average of the measurements from the two assays.  The dashed lines represent the 
mean of the bias and bias ± 1.96 standard deviations (SD).   
 
The effects of the extraction solution and evaporation process on lysozyme activity measured by 
the fluorescence-based activity assay are shown in Figure 4-5.  There were no statistically 
significant differences found between the percentage of active lysozyme after adding the 
extraction solvents (0.2% and 0.02% TFA/ACN solvents) and evaporation compared to the 
control (p > 0.05).  Samples that were evaporated without the addition of extraction buffers also 
showed no significant differences (p > 0.05).  In addition, the percentages of active lysozyme 







































Figure 4-5.  Percentage of active lysozyme recovered following the addition of extraction 
solvents (0.2% and 0.02% TFA/ACN) and evaporation.  The percentage of active lysozyme was 
determined for different lysozyme concentrations using the fluorescence-based assay. There 
were no significant differences between samples following the addition of extraction solvents 
and evaporation (p>0.05).    
 
The effect of contact lens extracts from lotrafilcon B, senofilcon A, etafilcon A and 
omafilcon A on lysozyme activity measured by the fluorescence-based assay is seen in  
Figure 4-6.  The presence of lens extracts from different lens materials did not show any 
significant effect on the percentage of active lysozyme in the samples (p > 0.05).  Similar to 
Figure 4-5, the percentages of active lysozyme recovered from all samples following the addition 








































Figure 4-6.  Percentage of active lysozyme recovered following the addition of contact lens 
extracts from lotrafilcon B, senofilcon A, etafilcon A and omafilcon A.  Active lysozyme was 
quantified using the fluorescence-based assay.  No significant differences were seen following 
the addition of lens extracts (p>0.05).   
   
4.5   Discussion 
 
 This study investigated the accuracy and sensitivity of a novel fluorescence-based 
lysozyme activity assay in comparison to the classical turbidity assay.  Furthermore, the 
compatibility of this novel technique for contact lens studies was examined.      
4.5.1 Comparisons between assays 
 
 Similar to the turbidimetric assay, the novel fluorescence-based assay utilizes the gram 
positive bacteria, Micrococcus lysodeikticus, and relies on the bacteriolytic function of lysozyme 
to quantify the amount of active lysozyme in solution.  Both assays have the ability to detect a 
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wide range of active lysozyme (Figures 4-1 and 4-2), however the current study determined that 
the fluorescence-based activity assay has a detection limit as low as 2ng, which provides a higher 
sensitivity compared to the turbidity assay (detection limit of 20ng).  Helal and colleagues
31
 have 
also reported similar findings in their recent work comparing the two assays.  They demonstrated 
that the limit of detection for the turbidity assay was 2.3units/mL whereas the fluorescence-based 
assay had a detection limit of 0.47units/mL.
31
 In comparison to the turbidimetric assay, the novel 
fluorescence-based assay generated comparable results when quantifying active lysozyme 
amounts that fell within the range of detection of both assays (Figure 4-3).  The small 
discrepancy or bias between the two methods was 0.474ng, indicating the measurements from 
the turbidity assay were slightly higher than the fluorescence-based assay, although all data 
points fell within the mean ± 1.96SD (-4.77 and +5.67ng, Figure 4-4).  While the two assays 
were comparable in quantifying active lysozyme, the bias between the two assays must be 
further evaluated in order to determine whether the discrepancy is large enough to be clinically 
relevant.   
The concentration of lysozyme in the human tear film varies during the day and under 





 reported that lysozyme levels in tears from patients diagnosed with pre-proliferative 
diabetic retinopathy have shown to have significantly higher tear lysozyme concentrations (2.77 
± 0.9mg/mL) compared to healthy controls (2.18 ± 0.6mg/mL).  Another study by Gupta and co-
workers 
41
 found that the tear lysozyme concentrations in patients diagnosed with severe and 
moderate acute adenovirus conjunctivitis had significantly lower tear lysozyme levels 
(0.9mg/mL and 1.13mg/mL respectively) compared to healthy subjects (1.45mg/mL).  Thus, 
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despite the slight variations between the two assays in the current study, the deviations were less 
than 3ng which may not be large enough to be considered clinically significant.   
4.5.2 Compatibility for contact lens studies 
 
 Extraction of protein deposits from contact lenses using a mixture of trifluoroacetic acid 
and acetonitrile was first used by Keith and colleagues
12
 and has since been adapted in more 
recent contact lens deposition studies.
17, 22, 28
  The proposed mechanism for the removal of 
proteins from the lens material is due to exchange of ions between the protein, solution and 
contact lens material, allowing the protein to readily solubilise in the extraction solvent.
12
  The 
current study demonstrated that the active lysozyme recovered following incubation in 0.2% and 
0.02% TFA/ACN solvent and/or evaporation was greater than 95% of the total lysozyme (Figure 
4-5).  This is in agreement with a recent study by Subbaraman et al,
22
 who reported a reduction 
in lysozyme activity of  2.1 ± 0.7% using the turbidity assay.  Previous studies that used 
TFA/ACN had demonstrated to efficiently remove over 90% of proteins from soft contact lenses, 
which allows for a representative analysis of the total content deposited.
12, 42
 Future studies may 
consider simply analyzing active lysozyme deposited on contact lenses using the fluorescence-
based assay by directly submerging the lens material into the substrate solution without the use 
of extraction procedures.  However, this will limit to only one aspect of analysis of the many 
deposits found on contact lenses and more importantly, it is unsure whether the presence of a 
contact lens may or may not impede with the fluorescent readings and will require further 
investigation.   
 The Gram positive bacteria, Micrococcus lysodeikticus, used for the fluorescence-based 
assay, were conjugated with fluorescent molecules in a way that the fluorescence is quenched.  
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Fluorescence quenching refers to the process in which the fluorescent signal of a substrate is 
suppressed.
43
 The intramolecular quenching is relieved when the bacterial cell walls are broken 
down by lysozyme.  Thus, in theory, a fluorescent signal would only be generated in the 
presence of lysozyme or other molecules that can lyse bacterial cell walls.  Previous work in our 
laboratory confirmed that samples containing lens extracts (without lysozyme) generated no lytic 
activity when quantified with the turbidity assay (unpublished).  This was also found in the 
current study, where the presence of extracts from the two silicone hydrogel lenses, lotrafilcon B 
and senofilcon A and the two conventional hydrogel lenses, etafilcon A and omafilcon A, 
indicated no differences in lysozyme activity compared to lysozyme samples containing no lens 
extracts (Figure 4-6).  The reduction in lysozyme activity of <5% was primarily caused by the 
extraction solvents and evaporation procedure, as mentioned previously, and not by the presence 
of contact lens extracts.  Therefore, the results suggest that the novel fluorescence-based assay 
displays high specificity to lysozyme activity, even in the presence of other impurities in the 
solution.    
Based on previous studies, the amount of lysozyme recovered from worn lenses ranges 
from over 1000µg per lens19, 28 to as low as 0.3-0.9µg per lens.29, 34  The detection range of the 
fluorescence-based assay was between 2-150ng, which falls well below the amount of lysozyme 





4.6   Conclusion 
 
 The fluorescence-based lysozyme activity assay has shown to be comparable to the 
classical turbidity assay, with the advantage of a higher sensitivity, which allows the analysis of 
low lysozyme amounts of as little as 2ng.  This is beneficial for studying contact lens materials 
that deposit relatively low levels of protein, since less sample volume will be required for the 
lysozyme assay, leaving ample volume for other analyses of the contact lens deposits. The 
activity of lysozyme was only marginally impacted by the 0.2% and 0.02% TFA/ACN solvent 
and/or evaporation process, leaving over 95% of the total lysozyme active.  Furthermore, lens 
extracts from lotrafilcon B, senofilcon A, etafilcon A and omafilcon A caused no interferences 
with the fluorescent readings from the novel assay.  In conclusion, the fluorescence-based 
lysozyme activity assay is a simple, sensitive and specific assay that is compatible for future 
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5.1   Overview 
 
Purpose:  To investigate the impact of lactoferrin and the presence of lipids on the kinetic 
denaturation of lysozyme deposited on silicone and conventional hydrogel lenses, using a 
complex artificial tear solution (ATS).   
Methods: Two silicone hydrogel lenses [AIR OPTIX AQUA; lotrafilcon B and ACUVUE 
OASYS; senofilcon A] and two conventional hydrogel lenses [ACUVUE 2; etafilcon A and 
PROCLEAR; omafilcon A] were incubated in four different solutions: an ATS consisting of 
various salts, lipids, proteins and mucins, an ATS without lactoferrin, an ATS without lipids and 
an ATS without lactoferrin and lipids. At various time points over a 28 day period the percentage 
of active lysozyme per lens was determined using a fluorescence-based activity assay and an 
enzyme-linked immunosorbent assay (ELISA). 
Results:   After 28 days, the percentage of active lysozyme recovered from etafilcon A lenses in 
all solutions was significantly higher than all other lens materials (p<0.001).  For lotrafilcon B, 
senofilcon A and omafilcon A lenses, lysozyme denaturation rates were greatest during the first 
week of incubation and reached a plateau after this time point (p>0.05).  The inclusion of lipids 
in the ATS significantly increased the lysozyme denaturation on both silicone hydrogel materials 
(p<0.001), while the presence of lactoferrin had an impact on lysozyme recovered from 
senofilcon A lenses (p<0.001).  Lysozyme activity on the conventional lenses was not 
significantly affected by either lactoferrin or lipids (p>0.05).           
Conclusions: Lactoferrin and lipids have an impact on the conformational state of lysozyme 
deposited onto silicone hydrogel contact lenses, while conventional hydrogel lenses seem to be 
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unaffected.  It is important for future in vitro studies to consider the impact of tear film 



















5.2   Introduction 
 
 Despite the development of disposable contact lenses, spoilage of contact lenses with 
various tear film components continues to be a problem for lens wearers. 
1, 2
  Immediately upon 





 and mucins 
7, 8
 and the accumulation of these tear film-derived deposits may be 
associated with lens discomfort, decreased visual acuity and increased symptoms of dryness.
1, 9-11
   
 The tear film spreads in a thin layer of approximately 3-7μm 
12, 13
 over the anterior 
surface of the eye and plays a key role in providing ocular defense against microbial agents.
14, 15
  
Various components contribute to the antibacterial defense system, including the abundant 
bacteriolytic enzyme lysozyme.
14
  Lysozyme catalyzes the hydrolysis of β1,4 glycosidic bonds in 
the cell walls of gram positive bacteria,
16
 enhances the phagocytosis of microorganisms by 
leukocytes and interacts with lactoferrin to provide ocular defense against bacteria.
17
        
Numerous studies have demonstrated that lysozyme is one of the major proteins 
depositing on and within soft lens materials.
18-23
  This low molecular weight (14kDa),
24, 25
 and 
positively charged enzyme deposits on both conventional (polyHEMA-based) and silicone 
hydrogel lens materials, particularly ionic materials exhibiting a negative charge.
22, 23, 26-29
  
Previous studies have found that once lysozyme deposits onto contact lenses, it undergoes 
conformational changes, 
27, 30, 31
 which may cause lens discomfort
32
 or ocular inflammatory 
reactions such as contact lens induced papillary conjunctivitis (CLPC).
33, 34
  Thus, in addition to 
quantifying lysozyme deposition on contact lenses, determining the conformational state of the 
deposited lysozyme is also of great clinical significance.  
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 Previous in vitro studies that examined lysozyme activity on contact lens materials often 
utilized simple tear film models in which to dissolve the lysozyme.
27, 30
 However, these simple 
models do not accurately represent the complex composition of the tear film, and do not consider 
the potential impact of other tear components on the sorption of lysozyme and the ensuing 
conformational state of the lysozyme deposited onto the lens material.  In recent studies, we have 
utilized more complex tear film models and found that the presence of lipids and other tear 
proteins, such as lactoferrin and albumin, have an impact on the amount of lysozyme deposited 
onto various lens materials. 
29, 35
  Thus, the aim of this study was to investigate the impact of 
specific tear film components on the kinetic conformational changes of lysozyme deposited on 
both conventional and silicone hydrogel lens materials using a complex artificial tear solution 
(ATS).     
5.3   Materials and Methods 
 
For this in vitro study, two silicone hydrogel lenses, lotrafilcon B (AIR OPTIX AQUA, 
CIBA Vision, Duluth, GA) and senofilcon A (ACUVUE OASYS, Johnson & Johnson, 
Jacksonville, FL) and two conventional hydrogel lenses, etafilcon A (ACUVUE 2, Johnson & 
Johnson, Jacksonville, FL) and omafilcon A (Proclear, CooperVision, Pleasanton, CA) were 
investigated. The dioptric power of the new, unworn lenses was -3.00D.  The individual 





Table 5-1.  Properties of contact lens materials investigated in this study 
 Silicone Hydrogel Conventional Hydrogel 




ACUVUE OASYS ACUVUE 2 PROCLEAR 
Manufacturer CIBA Vision Johnson & Johnson  Johnson & Johnson  CooperVision 
Water Content (%) 33% 38% 58% 62% 
Surface Treatment 
25nm plasma 
coating with high 
refractive index 
No surface treatment, 
but incorporates an 
internal wetting agent 
(PVP) 
None None 
FDA group I I IV II 







HEMA + siloxane 
macromer + PVP 
+TEGDMA 
HEMA+MA HEMA+PC 
DMA - N,N-dimethylacrylamide; FDA - Food and Drug Administration; HEMA - (poly-2-hydroxyethyl 
methacrylate);  MA - methacrylic acid; mPDMS - monofunctional polydimethylsiloxane; PC - phosphorylcholine; 
PVP - polyvinyl pyrrolidone; TEGDMA - tetraethyleneglycol dimethacrylate; TRIS - trimethylsiloxy silane; USAN 
United States Adopted Names 
 
5.3.1 Artificial Tear Solution (ATS) 
 
The ATS used in this study was a complex mixture of proteins, lipids, mucins, salts, 
glucose (all Sigma-Aldrich Canada Ltd., Oakville, ON, Canada) and urea (EMD Science, VWR, 
Mississauga, Canada) (Table 5-2). The composition of the ATS was adapted from a previous 
study by Lorentz et al
36 and has been used recently in our laboratory to investigate the effects of 
various tear film components on contact lens deposition.
29, 35, 37
 To study the impact of lactoferrin 
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and lipids on the conformation of lysozyme after depositing on contact lens materials, four 
variations of the ATS were used for incubation (Table 5-3).           
Table 5-2.  Composition of the artificial tear solution used in the study 
Salt Components (mg/mL) Lipids (mg/mL) 
NaCl 5.26  Oleic Acid 0.018  
KCl 1.19  Oleic Acid Methyl Ester 0.012  
Na2CO3 1.27  Triolein 0.016  
KHCO3 0.30  Cholesterol 0.0018  
CaCl2 0.07  Cholesteryl Oleate 0.024  
Na3C6H5O7 0.44  Phosphotidylcholine 0.0005  
Urea 0.072   
Glucose 0.036 Proteins (mg/mL) 
Na2HPO4 3.41  Bovine Albumin 0.20  
HCl 0.94  Hen Egg Lysozyme 1.90  
  Bovine Mucin 0.15  
Proclin 300 200µl per litre of solution Bovine IgG 0.02  
  Lactoferrin 1.80  
 
 
Table 5-3.  List of solution combination used for incubation 
Solution  
1 Complex ATS with all its tear film components (ATS) 
2 ATS without lactoferrin (ATS w/o Lcf) 
3 ATS without lipids (ATS w/o Lip) 
4 ATS without lactoferrin and lipids (ATS w/o Lcf & Lip) 





5.3.2 Pre-treatment of vials and lenses  
 
Glass vials (6mL, Wheaton Science Products, Millville, NJ, USA) were pre-treated for 7 
days at 37
o
C with the same solution used during lens incubation, with the exception of 
lactoferrin, which was excluded due to cost considerations. The purpose of this pre-treatment 
step was to coat the walls of the vials with pre-treatment solution, which reduces the adsorption 
of ATS components during the lens incubation and impacts on subsequent deposition levels (in 
house data, not reported).   
 Twenty-four hours prior to the incubation, lenses were removed from their blister 
packages using sterile silicone tipped forceps, rinsed in a saline solution for 2 seconds and then 
pre-soaked, at room temperature, in 5mL of an augmented buffered saline solution containing the 
salt components of the ATS (Table 5-2).  This procedure removed excess blister pack solution 
from the lenses. 
5.3.3 Incubation of lenses 
 
 Following pre-treatment of the glass vials, the pre-treating solution was replaced with one 
of the four incubation solutions (Table 5-3).  Lenses were removed from the saline solution and 
immediately placed in the vials.  All lenses were incubated in 1.5mL of incubation solution 
except for etafilcon A, which was incubated in 6.0mL.  The amount of lysozyme in 1.5mL would 
have been insufficient for etafilcon A, as this ionic lens type has been shown in previous 
studies
26, 27, 29
 to accumulate high amounts of lysozyme.  Thus, a higher volume was used for this 
lens type to allow for maximum uptake (in house data, not reported).  All vials were capped and 
placed inside a 37
o
C rotating incubator for 10 different time points (4 and 12 hours, 1, 2, 3, 5, 7, 
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14, 21, and 28 days).  Each condition had 3 replicates, thus a total of 480 contact lenses were 
used in this study.            
5.3.4 Protein extraction and evaporation 
 
 After each time point, lenses were removed from the vials and rinsed in saline solution 
for 2 seconds to remove unbound lysozyme from the lens surface.  Subsequently, the lenses were 
incubated in a protein extraction solvent composed of trifluoroacetic acid and acetonitrile (TFA 
and ACN) for 24 hours in the dark.  Lotrafilcon B, etafilcon A and omafilcon A were placed in a 
0.2% TFA/ACN solvent, 
21, 22, 38
 whereas senofilcon A was placed in a 0.02% TFA/ACN 
solvent.
39
  Previous studies from our group have shown that these extraction procedures results 
in lysozyme extraction efficiencies of >95%.
30, 40
 Lenses were inserted into 1.5mL of extraction 
solvent, except for etafilcon A, which has been previously shown to require 4.0mL of solvent.
38
  
Following extraction, two 500μL of the extraction solution was aliquoted into eppendorf tubes 
and dried down to pellets in a Savant Speed Vac (Halbrook, NY, USA).  Once dried, the samples 
were immediately re-suspended in a tear dilution buffer (TDB: 10mM Tris-HCl, 0.9% NaCl, 
1mM EDTA, pH 8.0) for analysis.   
5.3.5 Determining lysozyme activity  
 
 The conformational state of lysozyme extracted from the lens materials was assessed 
using the Enzchek® lysozyme activity assay (Molecular Probes Inc, Eugene, OR, USA).  This 
assay has been recently optimized in our laboratory for contact lens studies (paper in 
submission).
40
  Using 96 well black microplates (Costar, Fisher Scientific, VWR, Mississauga, 
Canada), 50µL of samples were added to 50µL of fluorescently tagged Micrococcus 
lysodeikticus in the wells.  The fluorescent signal was measured kinetically every 2 minutes for 
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30 minutes using excitation/emission of 485/530nm at 37
o
C (SpectraMax M5 Multi-Mode 
Microplate Reader, Molecular Devices, Sunnyvale, CA, USA).  The change in fluorescence over 
time for each sample was compared to a standard curve to determine the amount of active 
lysozyme in each sample. 
5.3.6 Quantification of total lysozyme    
 
 Total lysozyme deposited on the contact lenses was quantified using an enzyme-linked 
immunosorbent assay (ELISA).
41
  Using flat bottom 96-well plates (Maxisorp certified, Thermo 
Scientific, VWR, Mississauga, Canada), samples of 50µL were added to the wells and incubated 
at room temperature for 2 hours.  Subsequently, the wells were washed 3x using 300µL of the 
wash buffer (Phosphate buffered saline - PBS).  Then, 200µL of blocking solution (3% bovine 
serum albumin in PBS) was added to each well and incubated for 2 hours at room temperature.  
The wells were washed again 3x, followed by the addition of 50µL of 1/1300 rabbit anti-chicken 
lysozyme antibody (Meridian Life Science, MJS BioLynx, Memphis, TN, USA) to the wells. 
After 1.5 hours of incubation, wells were once again washed 3x and 50µL of the 1/5000 donkey 
anti-rabbit IgG-horseradish peroxidase linked antibody (Santa Cruz Biotechnology Inc., Santa 
Cruz, CA, USA) was added.  The incubation of the secondary antibody in the wells lasted one 
hour, before being washed 3x.  Subsequently, 50µL of 3,3'5,5',-tetramethylbenzidine reagent 
(Sigma-Aldrich Canada, Oakville, ON, Canada) was added to each well.  The plate was 
incubated for 5 minutes in the dark before 50µL of 1M H2SO4 was added to stop the reaction.  
The optical density (OD) of each well was measured at 450nm using the SpectraMax M5 Multi-
Mode Microplate Reader (Molecular Devices, Sunnyvale, CA, USA).  The absorbance values 
were compared to a standard curve to determine the total amount of lysozyme in each sample.   
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The percentage of active lysozyme quantified in each sample was calculated as follows: 
% Active Lysozyme  =  Active Lysozyme / Total Amount of Lysozyme   X   100% 
5.3.7 Statistical analysis 
 
Data analysis was conducted using Statistica 8 software (StatSoft Inc, Tulsa, OK, USA). 
A repeated measures analysis of variance (ANOVA) was used to determine statistically 
significant differences between the percentage active lysozyme across all time points and 
between materials and incubation solution. Further analysis was conducted using a post-hoc 
Tukey-HSD (Honestly Significant Difference) test. A p value of <0.05 was considered 
significant.  The denaturation of lysozyme was considered to plateau when no significant 
difference was found between the respective time point and day 28 (p>0.05). 
5.4   Results 
 
 The percentage of active lysozyme deposited onto the different lens materials after 
incubation in the complex tear solution (ATS) is shown in Figure 5-1.  After 28 days, lysozyme 
deposited on etafilcon A had the greatest activity (84.4 ± 3.6%), which was significantly higher 
than the other lens materials (p<0.001).  Lotrafilcon B and omafilcon A exhibited a similar 
reduction in activity, leaving a remaining 22.7% and 28.5% of active lysozyme respectively after 
1 week (p>0.05 between lens types).  The reduction in percentage active lysozyme on senofilcon 
A was not as high during the first week (60.7% active lysozyme) as compared to lotrafilcon B 
and omafilcon A, however, by the end of day 28, the amount of active lysozyme on senofilcon A 
was similar compared to lotrafilcon B and omafilcon A lenses (senofilcon A: 24.6 ± 1.0%; 




Figure 5-1.  Kinetics of percentage active lysozyme recovered from contact lenses over a 28 day 
incubation period in the artificial tear solution (ATS). Contact lens materials included lotrafilcon 
B , senofilcon A , etafilcon A  and omafilcon A .    
 
The percentage active lysozyme recovered from all lens materials incubated in the ATS 
without lactoferrin, the ATS without lipids and the ATS without lactoferrin and lipids is 
illustrated in Figures 5-2 to 5-4 respectively.  Lysozyme deposited on etafilcon A had 
significantly higher activity compared to the other lens materials on day 5 onward in the ATS 
without lactoferrin and in the ATS without lipids (Figures 5-2 and 5-3, p<0.001).  Similarly, 
lysozyme activity on etafilcon A in the ATS without lactoferrin and lipids was significantly 
higher in comparison to the other lenses following day 2 of incubation (Figure 5-4).  After 28 
days of incubation in the ATS without lactoferrin, the percentage active lysozyme was 77.8 ± 
4.6% for etafilcon A and ranged between 16.1 ± 4.0% to 32.2 ± 0.5% for lotrafilcon B, 
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senofilcon A and omafilcon A (Figure 5-2). When incubated in the ATS without lipids, the 
percentage active lysozyme on etafilcon A was 94.3 ± 0.2% and was between 34.8 ± 0.1% to 
40.6 ± 3.6% for the other lens materials following the 4 week incubation period (Figure 5-3).  
Furthermore, in the ATS without lactoferrin and lipids, the percentage active lysozyme was 87.5 
± 5.3% for etafilcon A and ranged between 31.6 ± 8.9% to 40.8 ± 0.4% for the other lens 
materials (Figure 5-4).  Overall, the rate of lysozyme denaturation on lotrafilcon B, senofilcon A 
and omafilcon A was similar throughout the 28 day incubation period in the ATS without 
lactoferrin, and the ATS without lipids and lactoferrin (Figures 5-2 and 5-4, p>0.05).        
 
Figure 5-2.  Kinetics of percentage active lysozyme recovered from contact lenses over a 28 day 
incubation period in the artificial tear solution without lactoferrin (ATS w/o Lcf). Contact lens 




Figure 5-3.  Kinetics of percentage active lysozyme recovered from contact lenses over a 28 day 
incubation period in the artificial tear solution without lipids (ATS w/o Lip). Contact lens 




Figure 5-4.  Kinetics of percentage active lysozyme recovered from contact lenses over a 28 day 
incubation period in the artificial tear solution without lactoferrin and lipids (ATS w/o Lcf & 
Lip). Contact lens materials include lotrafilcon B , senofilcon A , etafilcon A  and 
omafilcon A .    
 
Differences between incubation solutions for each material are shown in Figures 5-5 to  
5-8.   Figure 5-5 displays the kinetics of active lysozyme recovered from lotrafilcon B following 
incubation in all four solutions. Lysozyme activity dropped during the first 7 days before 
reaching a plateau in all solutions (p>0.05), with the exception of incubation in the ATS without 
lipids, where a plateau was reached at 52% active lysozyme on day 2.  The percentage of active 
lysozyme, in all solutions, was not significantly different for the first week (p<0.05).  After 7 
days of incubation, there was significantly more active lysozyme in the two ATSs without lipids 
(ATS w/o Lip and ATS w/o Lcf & Lip) compared to the two ATSs with lipids (ATS and ATS 
w/o Lcf) (p<0.001).  Throughout the 28 day incubation period, there was no significant 
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differences in active lysozyme between the two ATSs with lipids (p>0.05), and no significant 
differences between the two ATSs without lipids (p>0.05).  At the end of the 28
th
 day, the 
amount of active lysozyme was significantly higher in the ATS without lipids and the ATS 
without lactoferrin and lipids (45.6 ± 3.6% and 31.6 ± 8.9% respectively) compared to the ATS 
and ATS without lactoferrin (19.8 ± 1.1% and 16.1 ± 3.9% respectively) (p<0.05).   
 
Figure 5-5.  Kinetics of percentage active lysozyme recovered from lotrafilcon B lenses over a 
28 day time period.  The incubation solutions included a complex artificial tear solution with 
multiple tear film components (ATS) , an ATS without lactoferrin (ATS w/o Lcf) , an 
ATS without lipids (ATS w/o Lip)  and an ATS without lactoferrin and lipids (ATS w/o Lcf 
& Lip) . 
 
Figure 5-6 shows the reduction in active lysozyme recovered from senofilcon A after 
incubation in all four solutions.  During the first 4 hours of incubation, there were no significant 
differences in lysozyme activity in all solutions (p>0.05), until the 12
th
 hour, where the 
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percentage of active lysozyme was significantly higher in the two ATSs with lactoferrin (ATS 
and ATS w/o lip) compared to the other 2 solutions (p<0.001).  A reduction in lysozyme activity 
reached a plateau on day 7 in the ATS without lactoferrin (p>0.05) and was significantly lower 
compared to the other solutions from day 7 onward (p<0.001).  Similarly, lysozyme denaturation 
reached a plateau on day 7 in the ATS without lipids and ATS without lactoferrin and lipids 
(p>0.05).  There were no significant differences in the amounts of active lysozyme between the 
two ATSs without lipids from day 5 onward (p>0.05).  Furthermore, incubation in the ATS 
displayed a gradual decrease in percentage active lysozyme during the 28 day incubation, 
without reaching a plateau (p>0.001).  At the end of the 28-day incubation period, the ATS 
without lactoferrin and lipids (40.7 ± 0.4%) had significantly higher amounts of active lysozyme 
compared to the two ATSs that contained lipids (ATS; 24.6 ± 1.0% and ATS w/o Lcf; 19.4 ± 




Figure 5-6.  Kinetics of percentage active lysozyme recovered from senofilcon A lenses over a 
28 day time period.  The incubation solutions included a complex artificial tear solution with 
multiple tear film components (ATS) , an ATS without lactoferrin (ATS w/o Lcf) , an 
ATS without lipids (ATS w/o Lip)  and an ATS without lactoferrin and lipids (ATS w/o Lcf 
& Lip) . 
 
The kinetics of active lysozyme recovered from etafilcon A following the incubation in 
all four solutions is displayed in Figure 5-7.  There were no significant differences found in the 
amounts of active lysozyme, in all incubation solutions, throughout the 28 day time period 
(p>0.05).  The percentage of active lysozyme in all incubation solutions remained over 77.8 ± 




Figure 5-7.  Kinetics of percentage active lysozyme recovered from etafilcon A lenses over a 28 
day time period.  The incubation solutions included a complex artificial tear solution with 
multiple tear film components (ATS) , an ATS without lactoferrin (ATS w/o Lcf) , an 
ATS without lipids (ATS w/o Lip)  and an ATS without lactoferrin and lipids (ATS w/o Lcf 
& Lip) . 
 
 Figure 5-8 shows the decrease in the amount of active lysozyme recovered from 
omafilcon A after incubation in all four solutions.  There was a gradual decrease in percentage 
active lysozyme for all solutions until a plateau was reached on day 7 (p>0.05).  There were no 
significant differences in lysozyme activity, between all incubation solutions, throughout the 28 




Figure 5-8.  Kinetics of percentage active lysozyme recovered from omafilcon A lenses over a 28 
day time period.  The incubation solutions included a complex artificial tear solution with 
multiple tear film components (ATS) , an ATS without lactoferrin (ATS w/o Lcf) , an 
ATS without lipids (ATS w/o Lip)  and an ATS without lactoferrin and lipids (ATS w/o Lcf 
& Lip) . 
 
 Table 5-4 presents the amounts of total lysozyme deposited, expressed in micrograms per 
lens, and Table 5-5 reports the amount of denatured lysozyme, in micrograms per lens, following 
1, 7, 14 and 28 days of incubation.  The amount of denatured lysozyme (in micrograms) 
recovered from etafilcon A, in all solutions, was significantly higher than all other lens materials 






Table 5-4.  Total lysozyme deposited on silicone and conventional hydrogel contact lenses in all 
four incubation solutions, expressed in µg/lens (mean ± SD) 
Lens Solution Day 1 Day 7 Day 14 Day 28 
lotrafilcon B ATS 0.8 ± 0.1 0.9 ± 0.8 1.2 ± 1 1.2 ± 1  
ATS w/o Lcf 1.2 ± 0.2 1.4 ± 0.8 1.5 ± 1.1 1.5 ± 0.1 
ATS w/o Lip 1.8  ± 1 1.9 ± 1.3 1.9 ± 0.2  2.0 ± 0.5 
ATS w/o Lcf & Lip 1.9  ± 0.1 2.0 ± 2.0 2.0 ± 0.4 2.1 ± 0.4 
senofilcon A ATS 1.6  ± 0.1 2.2 ± 0.2  3.2 ± 0.1 3.5 ± 0.1 
ATS w/o Lcf 1.8  ± 0.1 2.1 ± 0.6 3.1 ± 0.7  3.2 ± 0.2 
ATS w/o Lip 2.3 ± 0.3 2.8 ± 0.1 3.7 ± 0.5 5.3 ± 0.2 
ATS w/o Lcf & Lip 1.9  ± 0.2 2.7 ± 0.3  3.7 ± 0.5 3.9 ± 0.2 
etafilcon A ATS 493.2 ± 46 1303.2 ± 34 1389.5 ± 54 1394.0 ± 67 
ATS w/o Lcf 492.4 ± 26 1309.9 ± 37 1380.8 ± 47 1393.7 ± 38 
ATS w/o Lip 477.9 ± 51  1370.8 ± 52  1413.3 ± 36 1490.2 ± 50 
ATS w/o Lcf & Lip 526.6 ± 29 1319.7 ± 33 1374.5 ± 43 1392.8 ± 47 
omafilcon A ATS 8.7 ± 3 10.1 ± 5 15.5 ± 9 19.9 ± 5 
ATS w/o Lcf 9.4 ± 4 10.8 ± 2 15.3 ± 6 18.9 ± 9 
ATS w/o Lip 10.2 ± 4 11.9 ± 6 16.1 ± 1 20.9 ± 9 







Table 5-5.  Denatured lysozyme deposited on silicone and conventional hydrogel contact lenses 
in all four incubation solutions, expressed in µg/lens (mean ± SD) 
Lens Solution Day 1 Day 7 Day 14 Day 28 
lotrafilcon B ATS 0.2 ± 0.1 0.7 ± 0.2 1.0 ± 0.1 1.0 ± 0.1 
ATS w/o Lcf 0.4 ± 0.4 1.0 ± 0.6 1.2 ± 0.3 1.3 ± 0.2 
ATS w/o Lip 0.6 ± 0.2 0.9 ± 0.5 1.1 ± 0.1 1.2 ± 0.6 
ATS w/o Lcf & Lip 0.5 ± 0.1 1.1 ± 0.6 1.3 ± 0.4 1.4 ± 0.3 
senofilcon A ATS 0.2 ± 0.1 0.9 ± 0.1 1.4 ± 0.2 2.6 ± 0.5 
ATS w/o Lcf 0.7 ± 0.1 1.6 ± 0.5 2.4 ± 1 2.6 ± 1 
ATS w/o Lip 0.4 ± 0.2 1.6 ± 0.1 2.2 ± 0.8 3.5 ± 0.6 
ATS w/o Lcf & Lip 0.6 ± 0.1 1.5 ± 0.2 2.1 ± 0.6 2.3 ± 1 
etafilcon A ATS 20.9 ± 9  160.1 ± 15 125.7 ± 20 217.3 ± 27 
ATS w/o Lcf 16.0 ± 8 113.1 ± 17 137.8 ± 22  309.3 ± 19 
ATS w/o Lip 28.3 ± 5 77.2 ± 16 77.7 ± 21 84.5 ± 12 
ATS w/o Lcf & Lip 16.3 ± 8 111.6 ± 11 123.5 ± 17 174.5 ± 18 
omafilcon A ATS 1.4 ± 0.8 7.2 ± 2 12.4 ± 6 15.4 ± 2 
ATS w/o Lcf 1.4 ± 0.3 7.1 ± 3 10.5 ± 3 12.8 ± 5 
ATS w/o Lip 1.6 ± 0.6 8.0 ± 1.5 10.3 ± 5 13.4 ± 7 




5.5   Discussion 
 
 This study monitored the effects of lactoferrin and lipids on the activity of lysozyme 
recovered from silicone and conventional hydrogel lens materials over a 28 day incubation 
period.   
5.5.1 Principles of protein adsorption and denaturation 
  
Protein deposition and denaturation on contact lenses is a complex process that begins 
immediately upon exposure of the material to the protein of interest.
20, 26, 29, 42, 43
  The sorption of 
proteins to biomaterials depends on a number of factors, including the hydrophobicity and ionic 
charge of the lens material,
20, 44
 as well as the size
20
 and abundance of the protein.
43, 45
  Proteins 
typically have a higher affinity for hydrophobic surfaces than hydrophilic surfaces, however, the 
presence of ionic interactions can greatly influence protein deposition on any surface.
20, 44
  For 
some lens materials, proteins accumulate on the contact lens surface and diffusely penetrate into 
the lens matrix,
46, 47
 which increases the total amount of protein that sorbs to a lens.        
Following the initial adsorption step, deposited proteins tend to rearrange their structure, 
allowing thermodynamically favourable interactions with the biomaterial surface.
44
  
Consequently, the protein partially loses its native structure or becomes “denatured”, and may be 
unable to perform its biological function.
48
 For instance, denatured lysozyme has reduced 
bacteriolytic activity compared to lysozyme in its native form.
49
  Several factors influence the 
degree and rate of denaturation of proteins on contact lenses, including the duration of 
exposure
30
 and  the chemical makeup and hydrophobicity of the lens material. 
30, 44, 50
  Proteins in 
their native state are folded in such a way that hydrophilic amino acids are exposed to the 
exterior side of the molecule, whereas the hydrophobic amino acids are hidden in the interior.  
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When proteins adsorb to hydrophobic surfaces, secondary and tertiary conformation may change, 
allowing thermodynamically favorable adsorption.
44
  Studies have suggested that lysozyme 
activity is less likely to reduce when proteins are able to accumulate in the lens matrix compared 
to lysozyme that is primarily bound to the contact lens surface.
18, 30, 50
 Ultimately, these factors 
may influence the biocompatibility of the contact lenses, as denatured protein on contact lenses 
has been associated with lens discomfort and papillary conjunctivitis.
32-34
 
5.5.2 Effects of lens material on lysozyme activity  
 
  Silicone hydrogel contact lenses have exceptional oxygen transmissibility.
51, 52
 However, 
these siloxane-based lens materials are more hydrophobic than poly2-hydroxyethyl methacrylate 
(pHEMA)-based materials and require surface modifications or integration of wetting agents to 
improve the wettability of the lens material.
53-55
 Lotrafilcon B is a silicone hydrogel material that 
is modified with a 25nm plasma coating on the lens surface.  Previous studies
5, 22, 26, 29
 have 
found low amounts of lysozyme deposited on lotrafilcon B, which may be largely influenced by 
its neutral surface charge, as well as the surface treatment that helps minimize the penetration of 
lysozyme into the lens matrix.
47
 The fact that lysozyme deposits mainly on the lens surface
56
 
may explain the higher degree of lysozyme denaturation as determined in our current study 
(Figure 5-1 to 5-4).   
 Senofilcon A lenses contain an internal wetting agent (polyvinyl pyrrolidone - PVP) to 
enhance the surface wettability of the lens.
55
 Lysozyme can be detected throughout the lens 
material and in slightly higher concentrations at the lens surface over time.
56
 The similar 
lysozyme deposition profile (distribution and total sorption) for senofilcon A and lotrafilcon B 
lenses may explain the similar reduction in lysozyme activity in both lens types over time 
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(Figures 5-1 to 5-4).  The only difference between these lens types was seen when lenses were 
incubated in the full artificial tear solution: senofilcon A lenses exhibited a slightly slower 
reduction in lysozyme activity over time compared to lotrafilcon B lenses (Figure 5-1).  This 
may be due to the presence of lactoferrin in the solution and will be discussed later in this 
discussion.         
 Omafilcon A is a conventional hydrogel material composed of polyHEMA incorporated 
with phosphorylcholine (PC), a substance associated with improved biocompatibility for various 
biomaterials
57, 58
  and, as contact lens materials, exhibit reduced protein adsorption.
59-62
  
However, despite its relative resistance to protein deposition, the amount of lysozyme that 
accumulates on omafilcon A typically ranges from 30 to 60µg,26, 27, 29 which is higher than the 
amounts deposited on the silicone hydrogel materials lotrafilcon B and senofilcon A.
5, 26, 27, 29
 
Lysozyme has been previously shown to diffusely penetrate into the matrix of omafilcon A,
47
 
which may explain the relatively higher quantities of lysozyme that sorbs to this lens type.  In 
addition, the surface wettability of omafilcon A, as determined by the sessile drop technique, was 
reported to be comparatively lower than other lens materials (ie exhibited a higher contact 
angle),
55
 which may increase the kinetic denaturation of lysozyme, as previously shown.
30
  This 
is in agreement with the current study, where the percentage of active lysozyme on omafilcon A 
dropped to between 20-41% in all four solutions during the first week of incubation, and 
remained at <36% of active lysozyme at the end of the 28 day period (Figures 5-1 to 5-4).  These 
values were comparable to the amounts active lysozyme recovered from lotrafilcon B and 
senofilcon A, which also displayed high degrees of lysozyme denaturation during the 4 week 
incubation period.           
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 In many previous studies, etafilcon A deposited significantly more lysozyme than other 
conventional and silicone hydrogel lens materials.
21, 22, 26, 29, 31
  This is due to the ionic monomer 
methacrylic acid (MA) employed within the lens material attracting the strongly positively 
charged lysozyme.
63-65
  In addition, etafilcon A has a relatively high water content and pore 
size,
66
 permitting significant amounts of lysozyme to diffuse into the lens matrix, as shown by 
confocal microscopy imaging. 
47
 Thus, unlike the silicone hydrogel lenses lotrafilcon B and 
senofilcon A, the ionic pores of etafilcon A allows lysozyme to readily diffuse into the lens 
material, which may influence the conformational state of lysozyme. In addition, the contact 
angle of FDA group IV contact lenses is lower than certain silicone hydrogel lens materials, 
implying that these lenses have a more hydrophilic surface.
55
 Etafilcon A-based materials have 
previously been shown to maintain a high percentage of lysozyme activity, 
18, 27, 30, 31
 which was 
further confirmed in the current study. During the 28 day period, >78% of the lysozyme 
deposited to etafilcon A remained active (Figure 5-7) and was significantly higher than other lens 
materials (Figure 5-1to 5-4).  However, it is important to consider that despite the high 
percentage of active lysozyme recovered from etafilcon A, the actual amount of denatured 
lysozyme (by mass) per lens on etafilcon A (which was as high as 309 ± 19µg) was significantly 
higher than all other lens materials (which ranged from 0.2 to 15µg) (Table 5-5).  For the 
etafilcon A material, the rapid thermodynamic interaction between the positively charged 
lysozyme and ionic surface will result in the majority of surface binding sites becoming occupied 
within hours of protein exposure, thus rapidly forming an initial monolayer of lysozyme, as 
described by Norde.
44
 Some lysozyme will penetrate into the lens matrix and will less likely 
denature in comparison to the surface bound lysozyme.  The high amounts of denatured 
lysozyme on etafilcon A could possibly be the surface bound lysozyme that initially formed the 
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surface monolayer.  This is in agreement with a recent study by Hall et al.
67
 where they 
discovered that the biological function of lysozyme deposited on etafilcon A lens materials 
rapidly reduces within the first 2 hours of exposure (up to 15% of surface bound lysozyme 
denatured).  Subsequently, lysozyme in the solution begins to accumulate over the top of the 
existing monolayer
44
 and will less likely denature, as they do not directly interact with the lens 
surface.  As a result, the subsequent layers of lysozyme and the lysozyme deposited within the 
lens matrix make up the total active lysozyme detected on etafilcon A.    
5.5.3 Effects of lactoferrin and lipids on lysozyme activity  
 
 Silicone hydrogel lenses accumulate relatively higher amounts of lipids than polyHEMA-
based materials,
22, 37, 68
 and it is suggested that these siloxane-based materials favourably adsorb 
lipids due to the hydrophobic to hydrophobic interactions between lipids and the lens surface.
4, 63, 
69
  In addition, the presence of lipids in an artificial tear solution has been previously shown to 
compete with the adsorption of lysozyme on lotrafilcon B lenses.
29
 This may imply that lipid 
deposits render the surface more hydrophobic, and as a result increase the denaturation of 
lysozyme. This current study also supports this concept, given that lysozyme activity on 
lotrafilcon B was significantly lower in the ATS solutions containing lipids compared to the ATS 
solutions without lipids after the first week of incubation (Figure 5-5).  Similar results were 
obtained with senofilcon A, where the percentage of active lysozyme was slightly higher in the 
ATS without lactoferrin and lipids and the ATS without lipids (although not significant) 
compared to the ATS and the ATS without lactoferrin by the end of the 28 day period 
 (Figure 5-6).  Moreover, the amount of active lysozyme in the two ATS solutions without lipids 
was significantly higher than when incubated in the ATS with lipids (without lactoferrin) 
throughout the 4 week incubation.  Interestingly, the percentage of active lysozyme on 
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senofilcon A in the ATS (consisting of lactoferrin and lipids) did not drop below the ATS 
solutions without lipids until after day 21.  Previous studies have shown that senofilcon A 
gradually deposits cholesterol (a major non-polar lipid in tears)
70, 71
 over a 20 day period
68
 and 
the addition of lipids in the incubation solution only impacted lysozyme deposition on senofilcon 
A after the 21
st
 day of incubation.
29
  This suggests that lysozyme activity on senofilcon A may 
not be affected by lipids until it reaches 3 weeks of lens incubation, which is of clinical relevance 
given that senofilcon A is a two-weekly replacement material. The presence of lactoferrin in the 
ATS may also influence the degree of lysozyme denaturation on senofilcon A, when compared 
to the other solutions.  Chow et al
72
 demonstrated that senofilcon A lenses accumulate similar 
amounts of lactoferrin  to lysozyme, during the first 2 weeks of incubation.
26, 29
  Lactoferrin is an 
antimicrobial protein that plays an important role in the ocular defense system against microbes, 
due to its inhibitory effect on bacterial growth. 
73
 Lactoferrin also maintains the antibacterial 
activity of lysozyme.
74-77
 This may explain why lysozyme activity was significantly lower after 
the first week on senofilcon A lenses incubated in the ATS without lactoferrin, compared to the 
other solutions.    
 In comparison to the silicone hydrogel lenses, the presence of lipids and/or lactoferrin did 
not significantly affect the conformational state of lysozyme on the two pHEMA-based materials 
throughout the study period (Figures 5-7 and 5-8).  Group IV lenses, such as etafilcon A, show a 
much lower affinity for lipids than proteins.
22, 63
  Chow and colleagues
72
 determined the kinetic 
deposition of lactoferrin on etafilcon A and found that the amount of lactoferrin deposited at the 
end of a 28 day period (11.3 ± 1.9µg) was only a fraction of the amount of lysozyme that 
deposits within the first 24 hours of exposure (>400µg).26, 29  Although the concentrations of 
lysozyme and lactoferrin were similar in the simple ATS used in these previous experiments 
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(1.9mg/mL vs 1.8mg/mL), lactoferrin is much larger than lysozyme (74kDa vs 14kDa), and the 
isoelectric point is lower for lactoferrin than for lysozyme (IEP pH=8.7 vs pH=11)
78, 79
 which 
explains the differences in the adsorbed quantities on etafilcon A. This suggests that the presence 
of lactoferrin and lipids would have minimal effects on lysozyme deposition quantity and 
activity for etafilcon A lenses due to the selective adsorption of lysozyme over both lactoferrin 
and lipids during incubation, which was confirmed in this study.      
Similar to etafilcon A, the activity of lysozyme on omafilcon A was not significantly 
affected by lactoferrin or lipids (Figure 5-8).  Previous studies have shown that omafilcon A  
accumulates relatively high amounts of lysozyme (compared with silicone hydrogel materials),
26, 
29




  In addition, previous work from our group 
demonstrated that the quantity of lysozyme deposition was minimally impacted by the presence 
of lactoferrin and lipids.
29
   
5.5.4 Comparison to in vitro studies  
  
 A number of previous studies have investigated protein denaturation on contact lenses, 
22, 
27, 30, 31
 and these results were comparable with the values reported in this study for the hydrogel 
lenses.  However, variations were noticed when comparing the outcomes obtained from previous 
studies for the silicone hydrogel lens materials examined. For example, the degree of lysozyme 
denaturation on lotrafilcon B and senofilcon A in this study (when incubated in the full ATS) 
was greater than that reported in previous in vitro work using a basic solution of PBS and 
lysozyme.
30
 These differences appear to be largely due to the presence of lipids in the incubation 
solution, which impacts the adsorption and denaturation of lysozyme on the silicone hydrogel 
lenses.       
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  Compared with the in vivo wearing situation, limitations of this study were that the 
lenses were constantly submerged in the ATS during incubation and the solutions were not 
replenished throughout the experiment.  This does not accurately portray contact lens wear, since 
lenses are frequently exposed to an air-water interface and the tear film is replenished with 
various components in an in-eye situation. Therefore, future in vitro studies should consider 
incorporating an artificial eye model that exposes contact lenses to the air, while consistently 
coating and wetting the lens material with a thin layer of an artificial tear solution that is 
replenished on a regular basis.    
5.6   Conclusion 
 
The degree of lysozyme denaturation that occurs varies between lens types and is 
dependent on the hydrophobicity of the lens surface and the location of lysozyme in the lens 
material. The presence of lactoferrin and lipids in an incubation solution did not impact 
lysozyme activity on the conventional polyHEMA-based hydrogel lenses etafilcon A and 
omafilcon A.  In contrast, the presence of lipids resulted in lower lysozyme activity for the 
silicone hydrogel lenses lotrafilcon B and senofilcon A.  Additionally, the presence of lactoferrin 
preserved the activity of lysozyme on senofilcon A.  Our results show that for in vitro studies 
examining deposition on silicone hydrogel materials that it is important to use complex models 
that closely mimic the human tear film. Future in vitro models should incorporate incubation 
solutions that are as close as possible to the composition of the human tear film and should 
consider methods to replenish the tear film components and build in the intermittent drying that 
occurs during the inter-blink period.  
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6.  General Discussion and Conclusion 
 
 This thesis has, for the first time, investigated the impact of lactoferrin and lipids on the 
kinetic deposition and denaturation of lysozyme on contact lenses using a complex artificial tear 
solution.  In addition, a novel fluorescence-based lysozyme activity assay was evaluated and 
utilized for the quantification of active lysozyme.  The following section provides a summary of 
the results obtained in each study.   
 The study in Chapter 3 examined the effects of lactoferrin and lipids on lysozyme 
deposition to both conventional and silicone hydrogel contact lenses.  The results have 
demonstrated that in the presence of lipids in the solution, the amount of lysozyme sorbed to 
lotrafilcon B and senofilcon A lens materials was significantly reduced.  This may be largely 
influenced by the higher amount of lipids that deposit on silicone hydrogel lens materials 
compared to lysozyme.
1-3
  In addition, the presence of lactoferrin in the solution significantly 
decreased the amount of lysozyme accumulated on lotrafilcon B, which was not observed with 
senofilcon A.  This could be explained by the competition for binding sites between lysozyme 
and lactoferrin on the lens surface.  Furthermore, the difference in deposition behavior between 
the two silicone hydrogel lenses may be influenced by the respective surface modification and 
overall material composition.  The amount of lysozyme detected on etafilcon A lenses was 
significantly higher compared to all other lens materials, due to the strong ionic interactions 
between lysozyme and the negatively charged lens material.
4-6
 Lysozyme deposition on etafilcon 
A lenses was significantly reduced when incubated in a solution without lipids.  It was 
hypothesized that lipids impede the adsorption of lactoferrin to this lens type, which may explain 
the increased binding of lysozyme.
7
  However, in the absence of lipids, lactoferrin can compete 
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for binding sites against lysozyme as they are both net positively charged proteins, which 
resulted in lower amounts of lysozyme deposits.  Furthermore, omafilcon A lenses accumulated 
similar amounts of lysozyme, independent of whether lactoferrin and/or lipids were present or 
absent in the incubation solution.  
 The study in Chapter 4 evaluated a novel fluorescence-based lysozyme activity assay for 
contact lens studies.  This method was compared with the lysozyme activity turbidity assay 
commonly used to measure lysozyme activity, and the results revealed that the two assays were 
comparable, with no significant differences between measurements. The turbidity assay typically 
reported slightly higher active lysozyme measurements than the fluorescence-based assay, 
nevertheless these discrepancies were not considered clinically significant.  Both methods have a 
wide range of detection, however, the novel fluorescence-based assay exhibited a lower detection 
limit, which is more favourable for studying the conformational state of lysozyme on contact 
lenses that deposit relatively low levels of lysozyme.  To determine the compatibility of the 
fluorescence-based assay for contact lens studies, typical extraction and evaporation procedures 
used in previous studies were investigated for interference with this assay.  The results showed 
that neither the use of extraction solvents containing trifluoroacetic acid/acetonitrile and/or 
evaporation significantly affected lysozyme activity.  Furthermore, contact lens extracts from the 
two silicone hydrogel lenses (lotrafilcon B and senofilcon A) and the two conventional hydrogel 
lenses (etafilcon A and omafilcon A) displayed no interference with the quantification of active 
lysozyme using the fluorescence-based activity assay.   
 The study in Chapter 5 investigated the effects of lactoferrin and lipids on lysozyme 
denaturation on both conventional and silicone hydrogel contact lenses, using the novel 
fluorescence-based assay evaluated in Chapter 4.  Results from this study indicated that the 
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presence of lipids in an artificial tear solution increased the denaturation rate of lysozyme on 
both lotrafilcon B and senofilcon A lens materials.  This could be associated with the relatively 
high levels of lipids that deposit on silicone hydrogel lens materials,
1-3
 which may increase the 
surface hydrophobicity of these materials and hence increase lysozyme denaturation upon 
adsorption.  In addition, lactoferrin helped maintain the activity of lysozyme on senofilcon A, 
which is in agreement with previous studies that suggested that lactoferrin has a synergistic 
effect on lysozyme activity against Gram positive bacteria.
8-11
 In contrast, the presence of 
lactoferrin and/or lipids had no significant impact on the activity of lysozyme deposited on both 
hydrogel materials.  This could be due to selective adsorption of lysozyme on these lens 
materials over both lactoferrin and lipids in the artificial tear solution.
1, 4, 12, 13
  Lastly, etafilcon A 
retained the highest amount of active lysozyme (over 78% remained active) following the 28 day 
incubation period, whereas the other lens materials, lotrafilcon B, senofilcon A and omafilcon A, 
exhibited a high degree of lysozyme denaturation during the first week (as little as 23% active 
lysozyme) before reaching a plateau for the remaining 3 weeks of incubation.  The 
hydrophobicity of the lens material and location of lysozyme deposition in/on the lens were 
suggested to impact conformational changes of lysozyme following adsorption.
14-17
   
 The current thesis project revealed that tear film components such as lactoferrin and 
lipids can alter the deposition profile of lysozyme through competitive interaction with various 
contact lens materials.  These results also suggest that tear film deposits on contact lenses 
interact with each other and can potentially influence the conformational state of deposited 
proteins such as lysozyme.  Silicone hydrogel lenses deposit relatively low amounts of lysozyme, 
possibly due to the competitive binding of lipids in the artificial tear solution.  Interestingly, 
despite depositing low amounts of lysozyme, the reduction in lysozyme activity on these lens 
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materials is significantly greater compared to the conventional hydrogel lenses that deposited 
higher amounts of lysozyme.  This begs the question of whether large amounts of lysozyme 
deposited on contact lens materials have a greater potential to maintain their conformational state 
than low amounts of deposited lysozyme.  Furthermore, patients fitted with silicone hydrogel 
lenses are prone to develop contact lens induced papillary conjunctivitis (CLPC).
18, 19
  The 
results from this thesis demonstrated that the degree of lysozyme denaturation on silicone 
hydrogel lenses is relatively high, particularly during the first week of incubation.  However, the 
amount of denatured lysozyme, by mass, is relatively low.  In contrast, etafilcon A maintained a 
relatively high percentage of active lysozyme throughout a 4 week period; however the amount 
of denatured lysozyme, by mass, is significantly higher compared to the amounts on silicone 
hydrogel lenses.  These findings continue the debate on whether CLPC is mainly developed 
through mechanical trauma (due to the physical presence of a lens) or do denatured proteins on 
contact lenses play a significant role in triggering this immunological response.  
         In comparison to previous in vitro studies, the results from the current thesis work 
displayed some variations in the amounts of lysozyme deposited.  In previous studies,
13, 20-22
 the 
amount of lysozyme accumulated on senofilcon A, etafilcon A and omafilcon A was higher than 
that reported in Chapter 3, while lotrafilcon B displayed comparatively lower lysozyme 
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Lotrafilcon B 10.4 ± 0.3 1.2 ± 1 
Ranging between 
3.7 ± 0.6 to 9.7 ± 1.5 
1.4 ± 1.1 
Senofilcon A 2.9 ± 0.1 3.2 ± 0.1 6.1 ± 3.2 1.6 ± 1.6 
Etafilcon A 694.8 ± 5.8 1389.5 ± 54 1433.5 ± 76 985 ± 241 
Omafilcon A 12.5 ± 0.2 15.5 ± 9 35.3 ± 8 N/A 
Total lysozyme deposition to contact lenses quantified using radiolabeling* or ELISA** 
This may have been largely influenced by the complex composition of the artificial tear 
solution used in this thesis as compared to the simple tear film models utilized previously.  
Furthermore, various components in the artificial tear solution could potentially have a greater 
preferential interaction with either the radiolabeled or non-radiolabeled lysozyme, which 
ultimately interferes with the accuracy of the radiolabeling technique.  This would not normally 
occur in previous in vitro studies
13, 20-22
 where other proteins, lipids and mucins were not present 
in the incubation solution.  In addition, free iodine atoms could potentially interact with other 
components in the artificial tear solution that deposit on the lens material, consequently leading 
to false positive/negative results.  Future work should investigate the differences in interactions 
between tear film components and radiolabeled or non-radiolabeled lysozyme, as well as 
incorporating a dialysis procedure to reduce the amount of free iodine in the radiolabeled 
samples.  When compared with ex vivo results,
1, 23, 24
 lysozyme uptake was similar to the current 
thesis work, particularly when using the ELISA for total lysozyme quantification (Table 6-1).  In 
addition, the reduction in lysozyme activity on all lens materials was almost identical to previous 
ex vivo results.  It is often difficult for in vitro studies to produce results that closely resemble 
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outcomes obtained in real life conditions.  Factors such as variations in the human tear film 
concentration during the day and under different health conditions, blinking and the constant 
replenishment of fresh tears over the anterior surface of the eye all influence contact lens 
deposition but are extremely hard to mimic in an artificial environment.  In comparison to 
previous in vitro models, the use of a complex artificial tear solution was relatively effective in 
closely mimicking the deposition and denaturation of lysozyme on contact lenses, especially the 
silicone hydrogel lenses, which are significantly impacted in the presence of lipids.   
In conclusion, the kinetic deposition and denaturation of lysozyme on contact lenses is 
affected by lactoferrin and/or lipids.  These effects were highly dependent on the chemical 
composition and properties of each lens material.  The results from these studies further support 
the importance of using complex artificial tear solutions that strongly portray the tear film when 
conducting in vitro studies investigating the interaction between tear film constituents and soft 
contact lens polymers.      
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7. Future Studies 
 
 This final chapter will focus on potential future projects that could follow-on from the 
results accumulated in this thesis.  The goal is to further enhance our understanding of the 
interactions between the tear film and contact lenses, which may ultimately facilitate in the 
future development of better and more biocompatible contact lens materials.    
Developing an artificial eye model to mimic contact lens wear 
 The in vitro model used in this thesis had a number of limitations which may impact the 
lysozyme sorption profile and therefore deviate from ex vivo findings.  Firstly, the lenses were 
not exposed to an air-water interface to simulate the blinking reflex, and this intermittent drying 
could potentially increase both lipid deposition and protein denaturation due to the increased 
hydrophobicity that occurs during the inter-blink period. Secondly, the incubation solutions were 
not replenished consistently as would occur during contact lens wear. Thirdly, the movement of 
the eyelid over contact lens during blink could impact tear film deposition on contact lenses. 
Finally, most lens wear schedules include an overnight cleaning cycle, which may further impact 
subsequent deposition profiles. Future studies should consider developing an artificial model that 
can expose contact lenses to the air while consistently spreading and replacing artificial tear fluid 
over and under the lens material and could consider including some option of lens cleaning at 
various phases during the incubation period.   
Investigating the impact of lipocalin on other tear film deposits   
 Another major protein identified in the tear film is lipocalin.
1
  This negatively charged 





Interestingly, tear lipocalin has been suggested to enhance the bacteriolytic function of 
lysozyme,
3
 and also acts as a lipid scavenger, which facilitates the removal of lipid contaminants 
in tears through the lacrimal duct.
4
  Lipocalin has a strong affinity for fatty acids, which is 
beneficial for lysozyme, as long chain fatty acids denature lysozyme in tears.
5-7
  Hence, it would 
be interesting to investigate whether the presence of lipocalin in an artificial tear solution can 
impact the subsequent deposition and denaturation rate of lysozyme.  In addition, given that 
lipocalin has a strong binding affinity for certain lipids, it would be interesting to determine if 
lipocalin can reduce the amount of lipids that deposit on silicone hydrogel contact lenses.  
Studying the oxidative degradation of lipids on contact lens materials   
 Lipids can undergo oxidative degradation resulting from loss of electrons under oxidative 
stress. 8 The degradation of tear lipids has been previously suggested to occur in conjunction 
with contact lens wear due to lens-induced hypoxia.
9
 Hence, it would be of interest to investigate 
the factors that influence lipid degradation on contact lenses and the effects of oxidized lipids on 
the denaturation of proteins deposited on contact lenses. Furthermore, it would also be 
interesting to study the potential impact of various tear film components on the stability of lipids 
deposited on contact lens materials. 
Evaluating patient worn lenses and compare with tear film concentrations   
 Tear concentrations often vary between individuals and are largely influenced by the 
individual’s age and health.
10-13
  As a result, the variations in their tear film may impact the 
degree to which individual tear film components deposit on contact lenses.  A future project 
could investigate how these differences in tear concentration influence contact lens deposition.  
For example, do patients with a relatively low tear concentration of lipids deposit less or more 
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lysozyme on their silicone hydrogel lenses?  The ex vivo results from these studies would 
potentially coincide with the current thesis work in determining the impact of tear film 
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